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Zusammenfassung 
Die Kation Chlorid Cotransporter (CCCs) stellen eine wichtige Klasse sekundär 
aktiver Membrantransportproteine dar, die in allen Organen des menschlichen Körpers 
vorkommen. Sie katalysieren den elektroneutralen Kation Cl
-
 Symport durch die 
Plasmamembran. CCCs spielen eine wichtige Rolle in der Regulation des 
Zellvolumens, beim Transport von Ionen durch Epithelschichten und in der Regulation 
intrazellulärer Cl
-
 -Konzentrationen. Im Laufe der letzten zwei Jahrzehnte wurden 
sieben humane Isoformen identifiziert und gemäss dem Kation, welches an den Cl
-
 
Transport gekoppelt ist, klassifiziert. Die Erforschung von Transporteigenschaften der 
humanen Transporter in HEK-293 Zellen ermöglichte die Messung von Ionenaffinitäten 
und die Identifizierung von Inhibitoren. Zusätzlich zeigten biochemische Experimente 
die dimere Organisation der NKCCs und die Bedeutung der C-terminalen Domäne für 
die Homooligomerisation. Obwohl die physiologische Rolle der verschiedenen 
Transporter bereits im Detail erforscht worden ist, gibt es bis heute keine strukturellen 
Informationen zu dieser Transporterfamilie. 
Im Rahmen dieser Dissertation wurden mehrere prokaryotische Homologe der 
Kation-Chlorid-Cotransporterfamilie identifiziert und deren Expression, Aufreinigung 
und Kristallisationsverhalten untersucht, um die erste CCC Struktur mit Hilfe der 
Röntgenstrukturkristallographie zu bestimmen. Das gesamte Protein und die isolierten 
C-terminalen Domänen dieser Homologe wurden kloniert und deren Expression unter 
verschiedenen Bedingungen getestet. Die Überexpression des Proteins wurde durch den 
T7- und PBAD Promoter in E.coli reguliert und für die meisten Proteine konnte dadurch 
eine Expression herbeigeführt werden. Eine GFP Fusion am C-Terminus wurde als 
Faltungsindikator verwendet, um frühzeitig Auskunft über die Qualität des Proteins zu 
erhalten. Nach der Extraktion des Transporters in Detergenzien konnten nur fünf 
Homologe mit ausreichender Proteinmenge aufgereinigt werden, die weitere 
biochemische Untersuchungen erlaubte. Obwohl vier der Transporter eine Tendenz zur 
Aggregation zeigten, nachdem sie aus der Membran gelöst wurden, konnte ein 
prokaryotisches Homolog aus der Familie der Archäen, Methanosarcina acetivorans 
C2A, MaCCC, vollständig in verschiedenen Detergenzien aufgereinigt werden. Dieses 
Konstrukt bildet ein wichtiges Modelsystem für zukünftige strukturelle und funktionelle 
Untersuchungen dieser Proteinfamilie.  
Um Einblicke in die strukturelle Organisation der CCC-Transporter zu erhalten, 
konnte während dieser Dissertation die Struktur der cytosolischen Domäne von MaCCC 
mit einer Auflösung von 1.9 Å bestimmt werden. Diese Struktur zeigt einen neuen 
Aufbau einer regulatorischen Einheit von Transportproteinen, und hat Ähnlichkeit mit 
 XII 
dem Aufbau von universellen Stressproteinen. Da die Quartärstruktur des Proteins in 
Kristallen nicht eindeutig war, wurden biochemische Methoden verwendet, um die 
oligomere Organisation zu charakterisieren. Die analytische Ultrazentrifugation und die 
Grössenausschlusschromatographie haben gezeigt, dass die Domäne in Lösung Dimere 
formt. Ein mögliches Dimer Interface, welches in den Kristallen beobachtet wurde, 
wurde durch zielgerichtete Cystein-Mutanten bestätigt, die in der Lage waren, 
Disulfidbrücken zu bilden. Da der gesamte Transporter ebenso Dimere bildet, konnte 
mit denselben Crosslinks, die Relevanz der beobachteten Interaktionen für das gesamte 
Protein gezeigt werden. Die Experimente liefern erste strukturelle Einblicke in die 
Familie der CCCs und etablieren die dimere Organisation der CCC Transporter. 
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Summary 
The Cation chloride cotransporters (CCCs) constitute an important class of 
secondary active membrane transport proteins that are ubiquitously expressed in human. 
They catalyze the electro-neutral cation-Cl
-
 symport across the plasma membrane. 
CCCs play an important role in cell volume regulation, the transepithelial movement of 
ions and the regulation of the intracellular Cl
-
 concentration (Gamba 2005). Seven 
human isoforms were identified over the last decade and classified according to the 
cation coupled to Cl
-
 transport. The investigation of transport characteristics of certain 
human transporters expressed in HEK-293 cells allowed the measurement of ion 
affinities and the identification of inhibitors. Additional biochemical experiments 
proposed the dimeric organization of NKCCs and the important role of the C-terminal 
domain for homo-oligomerization . While the physiological roles of different 
transporters were investigated in detail, the family still lacks structural representation. 
In the course of this thesis several prokaryotic homologues of the cation chloride 
cotransporter family have been identified and were investigated with respect to their 
expression, purification and crystallization behavior with the goal to determine the first 
CCC structure by X-ray crystallography. The full-length protein and the isolated C-
terminal domain of these homologues were cloned and tested for expression under 
different conditions. Protein overexpression was investigated in E. coli under the control 
of the T7- and the PBAD promoters. Under these conditions most proteins showed 
detectable expression. The addition of a C-terminal GFP fusion was used as folding 
indicator to determine the quality of the protein at an early stage. After extraction of the 
full-length transporter in detergents and purification, only five homologues provided 
sufficient protein for a biochemical characterization. While four of the transporters 
showed the tendency to aggregate once they were solubilized from the membrane, one 
prokaryotic homologue from the archaea Methanosarcina acetivorans C2A , MaCCC, 
allowed the purification of the full-length protein in different detergents. This construct 
provides an important model system for future structural and functional investigations. 
To gain insight into the structural organization of CCC transporters the structure of 
the cytosolic domain of MaCCC was determined in parallel at 1.9 Å resolution. This 
structure revealed the architecture of a novel fold for a regulatory unit of a transport 
protein that is distantly related to universal stress proteins. Since the quaternary 
structure of the protein in the crystals was ambiguous, biochemical methods were used 
to characterize the oligomeric organization. Analytical ultracentrifugation and size 
exclusion chromatography revealed that the domain forms dimers in solution. A 
possible dimer interface observed in the crystals was confirmed by the site-directed 
 XIV 
introduction of cysteine mutants that were able to form disulfide bonds. Since the full-
length transporter also forms dimers, the relevance of the observed interactions was 
confirmed by forming the same cysteine crosslink in the context of the full-length 
transporter. The experiments have thus provided a first structural insight into the CCC 
family and have established the dimeric organization of CCC transporters. 
 
 
  
1 Introduction 
1.1 Membrane Transport Proteins 
1.1.1 Membranes 
Membranes surround all living cells and their intracellular organelles. They are the 
direct interface between the inside and outside of the respective compartments. 
Membranes mainly consist of amphiphilic phospholipids. These molecules contain a 
hydrophilic head group of glycerol esters, a phosphate group, and hydrophobic tails of 
two fatty acid side chains. In water phospholipids spontaneously form lipid bilayers, 
where the head groups are pointed towards the water and the tails form a hydrophobic 
core. This core has a dielectric constant of about ε=2 which is drastically lower than the 
dielectric constant in water (ε=80). This property determines the permeability properties 
of the membranes. Non-polar molecules and small-polar molecules like water can pass 
the membrane to different extend, whereas charged ions or large-polar macromolecules 
such as proteins and nucleic acids are excluded from passage. Due to these dielectric 
features membranes behave like electric capacitors, a property that is used for the 
creation and conservation of the membrane potential. 
Membrane Proteins are associated with the lipid bilayer and functionalize the 
membranes. They have important functions in cell adhesion as well as for energy 
storage and they catalyze the specific transport of signals, metabolites, ions, proteins 
and other solutes across the membrane. Membrane proteins may be attached to the inner 
or outer surface or penetrate both leaflets of the membrane. The amphiphilic character 
of membrane proteins is characterized by a hydrophilic surface that is in contact with 
the aqueous solution or the polar headgroups of the lipids, and a hydrophobic belt that 
interacts with alkyl side chains of the lipids in the core of the membrane. 
Membrane Transport is dependent on a driving force that fuels the transport 
process. Passive transport or facilitated diffusion uses an existing concentration 
gradient. Solutes are passing the membrane to balance the concentration on both sides 
of the membrane. Active transport is an energy-dependent process that moves solutes 
across the membranes against their concentration gradient. Primary active transport 
directly uses chemical energy like hydrolysis of ATP for the transport of solutes and 
ions. Transported ions energize the membrane through an asymmetric distribution of 
charge and concentration on both sides of the membrane resulting in an electrochemical 
gradient. In cells this gradient is usually built up with protons (H
+
) resulting in a proton 
motive force or with sodium ions (Na
+
) creating the sodium motive force. Secondary 
active transporters use the energy stored in the ion gradient across the membrane to 
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transport solutes and ions against their concentration gradient. In animals, 
electrochemical gradients across the cytoplasmic membrane are due to the asymmetric 
distribution of Na
+
 and potassium ions (K
+
). 
The Membrane Potential of an animal cell is dominated by the three most abundant 
ions: K
+
, Na
+
 and chloride (Cl
-
). The controlled movement of these ions across the 
membrane underlies such important processes as electric signaling as well as the 
maintenance of the osmotic balance, and it provides energy for secondary active 
transporters. The membrane potential originates from two features: large concentration 
gradients for K
+
 and Na
+
 across the membrane and the selective permeability of the 
A 
 
B 
out
in
x
X
X
zF
RT
][
][
ln  
C 
Ion [intracellular], mM [extracellular], mM µx, mV 
K
+
 135 4 -92 
Na
+
 12 140 +64 
Cl
-
 4 116 -88 
Fig 1-1 The Membrane Potential 
A Na
+
, K
+
 and Cl
-
 are asymmetrically distributed on both sides of the membrane. Na
+
 and Cl
-
 are enriched 
in the extracellular space and K
+
 in the intracellular space. While Cl
-
 and Na
+
 have limited permeability 
across the membrane (dashed arrows) K
+
 can move across the membrane through open K
+
 channels (red 
arrow) creating a positive charge outside and a negative charge inside. B The resulting chemical potential 
of the ions can be calculated using the Nernst equation. X, electrochemical potential for ion X; R, gas 
constant; T, temperature; z, charge; F, Faraday constant; [X]in, concentration for ion X inside; [X]out, 
concentration for ion X outside. C For every ion X (K
+
, Na
+
, Cl
-
) a specific electrochemical potential can 
be calculated. 
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membrane for those ions mediated by selective-gated ion channels. The electrochemical 
potential under equilibrium conditions is a balance between the concentration-
dependent chemical potential and the permeability-dependent electrical potential.  
The chemical potential over the membrane derives from the concentration 
differences of K
+
 (135 mM inside and 4 mM outside the cell) and Na
+
 (12 mM inside 
and 140 mM outside the cell) (Fig 1-1A). The electrical potential results from the 
selective permeability of the membrane for certain ions. When K
+
 crosses the 
membrane through constantly open potassium channels following its concentration 
gradient, the negative counter ion remains intracellular. The resulting negatively 
charged inside and the positively charged outside of the cell creates an electrical force 
opposing the chemical force (Fig 1-1A). A net flux of K
+
 ions out of the cell will 
continue as long as the chemical potential is higher than the electrical potential. Under 
equilibrium conditions the chemical potential balances the electrical potential and can 
be described by the Nernst equation (Fig 1-1B) resulting in a defined electrochemical 
potential for each ion (Fig 1-1C). 
The transmembrane potential is depended on all ions and can be estimated 
considering the selective permeability of the membrane for each of the three major ions 
and their concentration distribution. The Goldman-Hodgkin-Katz Constant Field 
equation (Fig 1-2) describes the steady state potential taking all ion fluxes into account. 
Since K
+
 ions are highly permeable (10
-7
) for resting cells they dominate the 
electrochemical membrane potential, while Na
+
 ions have a two order of magnitude 
lower permeability (10
-9
). 
The resulting negatively charged interior of animal cells with respect to the external 
solution has an influence on the ion motive forces of Na
+
 and K
+
. Na
+
 following its 
chemical and electrical gradient exerts a higher force than K
+
 following its higher 
chemical gradient but moving against the electrical gradient. Thus, the Na
+
 motive force 
is more powerful and mostly used for energy-dependent transport processes. 
mVV
PPP
with
ClPNaPKP
ClPNaPKP
zF
RT
V
m
ClNaK
inCloutNaoutK
outClinNainK
m
84
10,10,10
][][][
][][][
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
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Fig 1-2 Goldman-Hodgkin-Katz Constant Field Equation 
The Goldman equation describes the membrane potential (Vm) using the concentration differences of the 
ions inside and outside of the cell ([X]in and [X]out, respectively (with X=K
+
,Na
+
 andCl
-
) and their 
selective permeability through the membrane (PX ). R, gas constant; T, temperature; z, charge; F, faraday 
constant. 
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1.1.2 Transporters and Channels 
Membrane transport proteins provide solutes with hydrophilic interactions to mimic 
the dielectric environment of water during transport across the membrane. Transporters 
and channels are the main classes of membrane ion transport proteins that can be 
distinguished by their mode of action. 
Transporters can use the energy from ATP hydrolysis or light (primary active 
transport) or the energy stores in an ion gradient (secondary active transport) to 
transport ions and solutes against their concentration gradient. During this catalytic 
process they work by an alternate access mechanism that requires at least two distinct 
protein conformations (Fig 1-3A). The two conformations expose substrate-binding 
sites to either site of the membrane and often have a high affinity for the cargo on one 
side of the membrane and a low affinity for the cargo at the other side of the membrane. 
In some cases, a defined occluded state is observed that represents the activated 
conformation during transport catalysis where the cargo is completely enclosed by the 
transporter. 
Channels facilitate diffusion of ions across the membrane along their chemical or 
electrochemical gradient. They consist of a transmembrane domain that contains the ion 
selectivity filter of the channel and a gate that prevents ion conduction through the 
channel in the closed state (Fig 1-3B). Channels can be ligand-gated, mechanically-
gated, voltage-gated or light-gated. 
Primary Active Transport is accomplished by membrane bound ATPases and by 
ATP binding cassette (ABC) transporters. Membrane bound ATPases translocate ions 
across the membrane and in that way build up of ion gradients for secondary active 
transport processes. Important members are the Na
+
/K
+
 ATPase (in the plasma 
 
Fig 1-3 Transporters and Channels 
Transporters and channels are the two most important classes of membrane transport proteins. They are 
classified based on their mode of action. (A) Transporters follow the alternate access mechanism with two 
distinct states exposing binding sites to either side of the membrane that have different affinities, high and 
low, for the cargo. A third occluded state encloses the cargo completely. (B) Channels are regulated by a 
gate to open and close the channel. 
1.1 Membrane Transport Proteins 
5 
membrane) (Morth, Pedersen et al. 2007), the H
+
/K
+
 ATPase (which is important in 
gastric acidification) and the Ca
2+
 ATPase (in the sarcoplasmatic reticulum of muscle 
cells) (Olesen, Picard et al. 2007).  
The Na
+
/K
+
 ATPase catalyzes the transport of 3Na
+
 outside and 2K
+
 inside the cell 
for each cycle of ATP hydrolysis. This results in an asymmetric ion distribution of Na
+
 
(12 mM inside to 140 mM outside the cell) and K
+
 (135 mM inside to 4 mM outside the 
cell) that is the basis for the membrane potential (see above). 
ABC transporters are driven by ATP hydrolysis on the inside of the cell to import 
(prokaryotes) or export (eukaryotes) their cargo. Recently, structures of all states during 
the transport cycle were elucidated and theories were formulated how the ABC motor 
domains convert the chemical energy into defined transport motions (Oldham, Davidson 
et al. 2008). 
Secondary Active Transporters couple the transport of one ion along its 
electrochemical potential with the translocation of the substrate against its concentration 
gradient across the membrane. They either work as symporters, where both molecules 
pass through the membrane in the same direction such as the Na
+
/glucose transporters 
(Abramson and Wright 2009) (Fig 1-4A), or antiporters such as H
+
/Cl
-
 transporters 
(Dutzler, Campbell et al. 2002) (Accardi and Miller 2004), where the downhill transport 
of ions in one direction provides energy for the active transport of the substrate in the 
opposite direction (Fig 1-4B). 
 
Fig 1-4 Secondary Active Transporters 
Secondary active transporters couple the transport of energized ion in two ways.  (A) Both move in the 
same direction through the membrane like in symporters or (B) in opposite directions as in antiporters. 
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1.2 Cation Chloride Cotransporters 
1.2.1 Overview of the Family 
Cation Chloride Cotransporters (CCCs) are found in all kingdoms of life where they 
play an important role in different physiological functions. They perform an electro 
neutral cation-Cl
-
 coupled symport that is secondary active (Gamba 2005). CCCs are 
divided into three big groups based on the cation coupled to the Cl
-
 transport (Fig 1-5). 
Sodium chloride cotransporters (NCCs, Fig 1-5B) transport one Cl
-
 together with one 
Na
+
 ion while potassium chloride cotransporters (KCCs, Fig 1-5C) couple one K
+
 per 
Cl
-
 ion. The third group, called sodium potassium cotransporters (NKCCs, Fig 1-5A), 
transport all three ions, Na
+
, K
+
 and Cl
-
 at a ratio of 1:1:2. Based on their 
pharmacological profile four groups were defined: 
 benzothiadiazine sensitive NCCs, 
 sulfamoylbenzoic (bumetanide) sensitive NCCs, 
 sulfamoylbenzoic (bumetanide) sensitive NKCCs and 
 dihydroindenoyloxy-alkanoic acid (DIAO) sensitive KCCs. 
The driving force of NKCCS and NCCs to transport ions inside the cell is the Na
+
 
motive force while KCCs use the K
+
 motive force for transporting ions outside of the 
cell. 
 
Fig 1-5 The Three Groups of Cation Chloride Cotransporters (CCCs) 
CCCs are divided into three groups based on the coupled cation that is transported with the chloride ion:   
A Na
+
-K
+
-Cl
-
-cotransporter (NKCC), B Na
+
-Cl
-
-cotransporter (NCC) and C K
+
-Cl
-
-cotransporter (KCC). 
They use the Na
+
 and K
+
 electrochemical gradient for transport (red triangles) which also defines the 
direction of ion movement: Inside for NKCCs and NCCs and outside for KCCs. The net charge 
transported is zero. The transport can be inhibited by various compounds: bumetanide (NKCCs, NCCs), 
benzothiadiazine (NCCs) and DIAO (KCCs). 
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In human one NCC, four KCC and two NKCC isoforms were identified. Sequence 
comparisons of these isoforms reveal a high sequence identity between Na
+
-driven 
cotransporters like NCC and NKCCs (around 50 %) with a lower sequence identity to 
K
+
-driven cotransporters (around 20 % identity between NKCCs and KCCs). The KCCs 
are clustered in pairs, KCC1 and KCC3 and KCC2 and KCC4 have highest mutual 
sequence conservation (Fig 1-6A and B). All isoforms show a distinct expression 
pattern. NKCC2 and NCC exist exclusively in the kidney and are apically expressed. 
NKCC1 is ubiquitously expressed on the basolateral side of the epithelial. KCC1 and 4 
are also ubiquitously expressed, while KCC2 is exclusively expressed in the central 
nervous system (CNS). KCC3 plays an important role in the CNS but is also detected in 
the inner ear and in vascular tissues. 
1.2.2 Physiology and Pharmacology 
CCCs have a major impact on cell volume regulation, transepithelial movement of 
ions and the regulation of the intracellular Cl
-
 concentration. 
Cell Volume Regulation is primarily an adaptation to the extracellular osmolarity by 
a variation of the internal osmolarity. The key players in this regulation are NKCCs and 
KCCs. If cells are exposed to a hypertonic environment they loose water and the cell 
shrinks. NKCCs transport Na
+
, K
+
 and Cl
-
 inside the cell and reduce the osmotic 
A 
 
B 
 
Fig 1-6 Phylogenetic Tree and Sequence Alignment of Human CCC 
A Phylogenetic analysis reveals the clustering of Na
+
-dependent CCCs (S12A1-NKCC2, S12A2-NKCC1, 
S12A3-NCC) and K
+
-dependent CCCs. Within the Na
+
 dependent CCCs, NKCCs (S12A1, S12A2) show 
a high sequence relationship. KCCs are subdivided into two branches consisting of KCC1 and KCC3 
(S12A4, S12A6 respectively) and KCC2 and KCC4 (S12A5, S12A7 respectively). B The sequence 
alignment between the 7 human CCCs shows a high homology between the family members. Identical 
residues are colored in red, similar residues are colored in ruby. The topology prediction is indicated 
based on NKCC2 (S12A1) with putative transmembrane helices (tm) 1 and 2 and the intracellular 
connecting loop 2. 
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differences to the extracellular space and thus recover the original cell volume. Since 
KCCs facilitate the transport of ions out of the cell they play an important role when the 
cell senses hypotonic conditions. The extrusion of KCl increases the water efflux and 
thus prevents cell swelling. 
Transepithelial Movement of Ions is particularly important for the reabsorption of 
salt in the kidney. NCCs are expressed apically in the distal convoluted tubule (DCT) 
and NKCC2 apically in the thick ascending loop of Henle (TALH). Both proteins are 
major proteins involved in the translocation of ions from the lumen into the cells. 
NCCs provide the major sodium reabsorption pathway along the DCT (Fig 1-7). 
They facilitate the transport of sodium chloride (NaCl) into the cell driven by the Na
+
- 
concentration generated by the basolateral polarized Na
+
/K
+
 ATPase. The accumulated 
K
+
 that enters the cell through the Na
+
/K
+
 ATPase is secreted to the lumen via apical 
KCCs and ROMK K
+
 channels. This process also influences the Ca
2+
 reabsorption 
through Ca
2+
 channels in the apical membrane. If NCCs are blocked through thiazide-
type diuretics an electrical gradient is created because the Na
+
/K
+
 ATPase continuously 
reduces the Na
+
 concentration in the cell. Thus, the entry of Ca
2+
 is promoted. The use 
of thiazides like chlorthalidone, hydrochlorothiazide, bendroflumethaizide and 
metolazone are used as drugs against hypertension and calcium stones and osteoporosis. 
NKCC2 is the primary NaCl reabsorption pathway in the TALH that is responsible 
for the reabsorption of 15-20 % of the glomerular filtrate (Fig 1-8). The basolateral 
polarized Na
+
/K
+
 ATPase creates a membrane potential that drives the inward transport 
of Na
+
, K
+
 and Cl
-
 by NKCC2 from the lumen into the cell. Na
+
 and Cl
-
 leave the cell 
basolaterally through the Na
+
/K
+
 ATPase and CLC-K, respectively. K
+
 is transported 
back to the potassium-ion depleted tubular lumen via the ROMK K
+
 channel to recycle 
K
+
 for the NKCC2-dependent transport. During this transport cycle a positive charge 
 
Fig 1-7 Role of NCCs in the Transepithelial Movement of Ions 
The transepithelial salt movement in the distal convoluted tubule (DCT) is a team play between the 
Na
+
/K
+
 ATPase (red) that creates the Na
+
 motive force and NCCs (blue, top), the major salt transport into 
the cell. KCCs (blue, bottom) facilitate the K
+
 transport back into the lumen. The K
+
 transport through K
+
 
ROMK channels (light grey) back into the lumen promotes the reabsorption of Ca
2+
 through Ca
2+
 
channels (dark grey). Thiazides inhibit NCCs and stop reabsorption of ions from the lumen. (Gamba 
2005) 
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remains in the tubule originated from the extruded K
+
 that drives the diffusion of one 
Na
+
, Ca
2+
or Mg
2+
 through a paracellular pathway across the tight junctions into the 
interstitial space. The major ammonia reabsorption in the TALH is facilitated by the 
replacement of K
+
 in NKCC2 by ammonium resulting in a Na
+
/NH4
+
/Cl
-
 cotransport. 
The most potent loop diuretics like furosemide or bumetanide that target NKCC2 
produce a significant natriuresis and diuresis, and are used against hypertensions and 
hypercalcemia. 
NKCC1 is involved in transepithelial ion movement in epithelial secretory cells (Fig 
1-9). Basolateral polarized NKCC1 provides the cells with Cl
-
 that is secreted through 
the apical membrane. Na
+
 is recycled via the Na
+
/K
+
 ATPase and K
+
 through a 
conductive pathway in the basolateral membrane. Cl
-
 in contrast is secreted into the 
 
Fig 1-8 Role of NKCC2 in Transepithelial Ion Movement 
Salt reabsorption in the thick ascending loop of henle (TALH) is driven by the concentration gradients 
created by the basolateral polarized Na
+
/K
+
 ATPase. NKCC2 (blue) facilitates the movement of Na
+
, K
+
 
and Cl
-
 from the lumen into the cell. K
+
 is recycled to the lumen via ROM-K K
+
 channels (gray, apical). 
Cl
-
 is transported out of the cell via basolateral CLC-K channels (grey, basolateral). Other cations (Na
+
, 
Ca
2+
, Mg
2+
) are reabsorbed into the interstitial space via tight junctions. Loop diuretics inhibit NKCC2 
and deactivate reabsorption of ions from the lumen. (Gamba 2005) 
 
Fig 1-9 Role of NKCC1 in Transepithelial Ion Transport 
In epithelial secretory cells the basolateral Na+/K+-ATPase (red) is creating a concentration gradient that 
fuels the uptake of salt via NKCC1 (blue) into the cell. Cl
-
 is secreted to the lumen via chloride channels 
(grey) e.g. the cystic fibrosis transmembrane conductance regulator (CFTR). (Gamba 2005) 
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lumen via several pathways. Cystic fibrosis transmembrane conductance regulator 
(CFTR) is the most important Cl
-
 dislocator in the apical membrane. This pathway is 
essential for the acidification of the stomach and in the maintenance of the mucosal 
fluid viscosity in the lung which is impaired in cystic fibrosis. 
Regulation of the Intracellular Cl
-
 Concentration plays an important role in the 
regulation of γ-aminobutyric acid (GABA) and glycine mediated responses in neurons 
(Schomberg, Bauer et al. 2003). KCC2 that is exclusively expressed in the CNS defines 
together with NKCC1 the type and magnitude of responses to neurotransmitters in the 
development and maturation of neurons. GABA binding to the GABA receptor 
mediates the opening of a ligand-gated Cl
-
 channel. Depending on the Cl
-
 concentration 
in the neuron, the Cl
-
 channel opening results in a Cl
-
 efflux and depolarization or Cl
-
 
influx and hyperpolarization. In immature neurons, the Cl
-
 concentration is above the 
electrochemical equilibrium due to high expression rates of NKCC1 and low expression 
rates of KCC2. Responses to GABA are thus excitory due to a depolarization of the 
membrane potential. Mature neurons, in contrast, contain a Cl
-
 concentration that is 
below its electrochemical equilibrium due to a downregulation of NKCC1 and a high 
expression of KCC2. This results in the influx of Cl
-
 upon to GABA receptor activation 
because of the hyperpolarization of the membrane. 
1.2.3 Structure and Function 
CCCs are 120-200 kDa big, homodimeric glycoproteins. They share a common 
architecture that is composed of a relatively small intracellular N-terminus (41-285 
residues) followed by a transmembrane domain (~470 residues for Na
+
-dependent 
CCCs to ~540 residues for K
+
-dependent CCCs) and a large intracellular C-terminal 
 
Fig 1-10 Simplified Sheme of the Topology of NKCCs 
NKCCs are proposed to consist of 12 transmembrane helices. The small N-terminal domain and the C-
terminal domain are both located in the cytoplasm. Two glycosylation sites were identified between 
transmembrane segment 7 and 8. In NKCC2 an exclusive exon cassette starting in the middle of 
transmembrane helix 2 to the middle of the connecting intracellular loop defines the splice variants A, B 
and F (red). 
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domain that constitutes nearly half of the protein (413-480 residues). The 
transmembrane domain is predicted to harbor 12 transmembrane spanning segments 
(Fig 1-10). For the three different groups of CCCs distinct glycosylation sites have been 
identified. NKCCs and NCC have two glycosylation sites in the loop between helix 7 
and 8 and KCCs four sites between helix 5 and 6.  
Sequence Comparisons between all members of the CCC superfamily reveal 
valuable information about the homologies within the family and the conservation of 
the three topological domains (N-terminus, transmembrane domain and C-terminal 
domain). The pair-wise sequence comparisons of the full length proteins gives rise to 
the already mentioned clustering into two subfamilies of Na
+
- and K
+
-driven family 
members (see above 1.2.1). While most of the putative helices align well between these 
two groups, clear differences in loop lengths are apparent. Particularly the respective 
loops harbouring the glycosylation sites are longer in KCCs. Overall the sequence 
conservation is highest for the membrane domain and lower at the C-terminal domain. 
Among the three parts of the protein the N-terminal tail is least conserved. The 
membrane domain contains the specific binding sites for the substrates and it catalyzes 
the transport and thus shows the highest sequence conservation (Fig 1-6B). The C-
terminal domain, in contrast, has important regulatory functions for activation and 
deactivation by phosphorylation or potential ligand binding and serves as interaction 
platform with other proteins (Moore-Hoon and Turner 2000; Mercado, Broumand et al. 
2006). Additionally the C-terminal domain was suggested to play a role in the subunit 
recognition and thus to prevent hetero-oligomerization (Parvin, Gerelsaikhan et al. 
2007). This demand for selectivity could explain the significant lower conservation. The 
amino terminus that is the most variable segment in length has a reasonable identity 
among KCCs (~45 %) but is not conserved between the subfamilies (<30 %). 
Nevertheless, it was shown to have important regulatory functions via phosphorylation 
(Gimenez and Forbush 2005; Anselmo, Earnest et al. 2006). 
The best characterized members of the CCC family are the sodium dependent 
transporters NCC and NKCC1/2. They were the first identified electroneutral 
cotransporters, are abundant among the animal kingdom and have a distinct expression 
pattern in mammals. NKCCs are particularly suited for functional investigations 
because they exist in different isoforms and have splice variants with distinguishable 
properties. 
NKCC2 is of specific interest because three splice variants exist (NKCC2A, 
NKCC2B, NKCC2F) that each contains a variation of 31 residues (Fig 1-11C) (Gamba 
2005). This variation concerns a region in the C-terminal half of transmembrane helix 2 
and the first part of the consecutive intracellular loop and is responsible for differences 
in the ion transport characteristics of the splice variants. Additionally, a long (NKCC2-
l), (Fig 1-11A) and short version (NKCC2-s), (Fig 1-11B) exist that differ in the length 
of their C-terminus (329 residues to 55 residues, respectively). NKCC2A, B, F are 
distributed along TALH according to their different ion affinities and transport rates. In 
1 Introduction 
12 
the outer medulla where the primary urine still has a high salt concentration the 
isoforms F with the lowest affinity and highest transport rate is expressed. Isoform A, 
which is spread all along TALH, shows high transport rates with moderate affinity.  
Isoform B possessing the highest affinity for the transported ions and is solely expressed 
in the cortex, where the ion concentration in the tubular fluid has been greatly reduced. 
On a sequence level, these changes in affinity (factor 3 to 7 for Na
+
, 2 to 3 for K
+
, 3 to 
12 for Cl
-
 for mouse and rabbit, respectively) are accomplished by minor changes of 
only three residues (Fig 1-11C). 
The physiological role of NKCC2-s is still poorly understood. Functional 
experiments in Xenopus laevis oocytes suggest two different roles: as regulatory 
molecule and as cotransporter. As regulatory molecule, NKCC2-s has a negative effect 
on NKCC2-l function that can be abrogated by cAMP. The presumed mechanism, as 
shown by fluorescence analysis, is the prevention of NKCC2-l to reach the plasma 
membrane. The observed activation of NKCC2-l by cAMP can be interpreted as an 
effect of cAMP producing hormones like vasopressin via their G protein-coupled 
receptors (GPCRs). NKCC2-s also appears to function as K
+
-independent Na
+
/Cl
-
 
cotransporter as shown in X. laevis oocytes with murine NKCC2-s. This behavior was 
 
Fig 1-11 Splice Variants of NKCC2 
NKCCs are proposed to consist of 12 transmembrane helices. The small N-terminal domain and the C-
terminal domain are both located in the cytoplasm. Two glycosylation sites were identified between 
transmembrane segment 7 and 8. Due to splice events a long NKCC2-l (A) and a short NKCC2-s exist 
(B), which differ in the length of their C-terminus (329 residues in the long and 55 residues in the short 
isoforms). (C) Within the long and the short version of NKCC2 a region starting in the middle of 
transmembrane helix 2 (tm2) to the middle of the following intracellular loop defines the splice variants 
A, B and F (illustrated for mouse NKCC, mNKCC). Each splice variant is distinguished by three residues 
that are changed in all exons (red boxes) (orange-A, blue-B, green-F). 
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observed in hypotonic solution and was abolished by exposure to an isotonic 
environment or stimulation of cAMP production via vasopressin. In these cases, 
NKCC2-l was the major expressed protein and the apical transport switched to 
Na
+
/K
+
/Cl
-
 cotransport.  
The human and shark orthologues of NKCC1 share high identity (74 %) but have 
different affinities for the transported ions (six times higher for hNKCC1) and for 
bumetanide inhibition. Different chimaeras of the two organisms were analyzed for their 
transport characteristics in transfected HEK-293 cells (Isenring and Forbush 2001). The 
hybrid constructs were compared with the wild type to identify transmembrane 
segments responsible for ion and inhibitor binding. The transmembrane region (Tm) 2 
plays an important role in Na
+
 and K
+
 transport, while Tm 4 was shown to influence the 
K
+
 and Cl
-
 transport characteristics. Tm 7 is crucial for the transport of all three ions: 
Na
+
, K
+
, and Cl
-
. Bumetanide binding, in contrast, could not be assigned to any specific 
region (Fig 1-12). 
The high presence identity between the orthologues, with variation in single residues 
allowed the identification of few amino acids within the segments that account for the 
observed changes. During these experiments also the influence of the cytosolic N- and 
C-terminal domains on transport was also investigated. In these investigations no 
changes in transport properties and inhibition characteristics upon altering the cytosolic 
domains could be detected. The ion and inhibitor affinities are thus solely determined 
by the transmembrane domain. Similar experiments were performed using the rat and 
winter flounder orthologues of NCC which have led to the same conclusions. 
 
Fig 1-12 Distribution of Ion Specificity on Transmembrane Segments of NKCC1 
Relative change in the transport characteristics of hNKCC1 - shark NKCC1 (sNKCC1) chimeras. The 
affinity change of the chimera (compared to sNKCC1) for the transported ions (Na
+
, Rb
+
, Cl
-
) are plotted 
against the predicted transmembrane domains. Rb
+
 is used as replacement for K
+
. (Isenring and Forbush 
2001) 
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1.2.3.1 Prokaryotic Homologues as Model Proteins 
High throughput sequencing efforts of organisms provide a growing repertoire of 
prokaryotic genomes. The identification of prokaryotic homologues of eukaryotic 
transport proteins has accelerated the structural investigation of membrane proteins for 
several reasons. First, because prokaryotic expression systems, particularly E. coli, have 
been much more investigated and developed than eukaryotic expression systems. 
Second, because prokaryotic proteins are easier to overexpress and purify in large 
quantities. In contrast to their eukaryotic counterparts these proteins mostly lack 
extensive, unstructured loops, posttranslational modification like glycosylation and are 
usually not phosphorylated. A particularly promising class of proteins derives from 
extremophile sources like thermophiles, because they are believed to harbor very stable 
proteins important for solubilization, purification and crystallization. Working with 
various prokaryotic homologues thus offers the possibility to test related proteins that 
share the same structure and function but have remarkably different properties. 
Prokaryotic homologues have traditionally been called evolutionary related and to 
belong to the same family if they have a sequence identity >30 % in a pair-wise 
alignment (Granseth, SeppÃ¤lÃ¤ et al. 2007). Identity above this margin is a clear 
evidence for a functional and structural relationship. However, during the last years this 
threshold has been found to be significantly lower. Functional experiments that have led 
to the identification of essential residues and information of architectural features of the 
proteins by biochemistry have allowed reducing the cut-off for identical residues. 
Various structures of prokaryotic membrane protein homologues have previously been 
determined with lower conservations to their eukaryotic counterparts that clearly belong 
to the same family. In the case of ClC chloride channels and transporters the sequence 
identity between the human family members is already relatively low with 21.9 % 
(hClC-0 to hCLC-5). The prokaryotic homologue of E. coli, EcClC, has a sequence 
identity to hClC-5 of 16.6 %. Nevertheless the sequence conservation is high in regions 
of functional importance. The structure of EcClC allows the localization of conserved 
residues of which some form the ion translocation pore with specific ion binding sites. 
For CCCs a number of prokaryotic homologues could be identified. They share a 
unusually high degree of sequence identity (above 30 %) to their human counterpart 
NKCC2 (Fig 1-13). The conservation is especially high in the transmembrane domain 
(residue 178 to 813 for NKCC2). Unlike their mammalian counterparts, the prokaryotic 
transporters lack extensive loops between defined structural elements (loop residue 345-
356 and loop residue 439-475 for NKCC2) and for prokaryotic CCC homologues the N 
terminal domain (residue 1-174) (Fig S-1). 
The insights gained from the structures of prokaryotic homologues have guided the 
interpretation of functional experiments on eukaryotic family members. Particularly the 
basic transport mechanisms and substrate specificity are usually conserved between the 
pro- and eukaryotic species barrier. The prokaryotic structures of membrane proteins 
thus also provide a structural framework for follow-up experiments on the eukaryotic 
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counterpart. While general mechanisms are conserved, certain regulatory and 
pharmacological properties often differ between pro- and eukaryotic transporters. The 
cellular regulation of specific family members, the binding of drugs and the role of 
unstructured regions will ultimately require the structural investigation of eukaryotic 
CCCs. 
1.2.4 Crystallization and Structure Solution of Membrane Proteins 
The knowledge of detailed spatial arrangements of amino acids in the structure of a 
protein is crucial for the in depth analysis of its function. Two methods are widely used 
to extract this information: X-ray diffraction of protein crystals and nuclear magnetic 
resonance (NMR) in solution. NMR offers the possibility to extract information on 
dynamic behavior of the protein and it does not require crystals but it is limited by the 
size of the biopolymer (around 30 kD). Crystallography in contrast freezes one 
conformation of the protein in a crystalline array and thus allows the detailed structure 
determination of proteins and complexes even exceeding 1 Mega-Dalton. 
 
Fig 1-13 Sequence Alignment Between Human and Prokaryotic CCCs 
Human NKCC2 (S12A1) was aligned with a prokaryotic homologue from Plactomyces maris (37 % 
identity). The numbering (above) corresponds to the residue number of S12A1. The coloring is according 
to conservation (red=identical residues, ruby=very homologues residues). The region of highest 
conservation is located within the transmembrane domain (residue 174 to 813 for S12A1, blue box). 
Insertions in presumed loop region within the eukaryotic transporter are colored in yellow. 
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The structural analysis of proteins demands milligram amounts of pure protein. This 
requirement is a major hurdle towards structure determination. The expression, 
purification and crystallization of membrane proteins are particularly difficult for a 
number of reasons. Due to their localization in membranes these proteins expose a 
hydrophobic surface and can thus only be solubilized in the presence of detergents 
which results in poor stability and increased flexibility in solution. 
Membrane proteins are usually either purified from natural sources or heterologously 
overexpressed in different expression systems. Eukaryotic proteins of known structure 
have been mainly purified from tissues where they are naturally enriched. Rhodopsin 
was isolated from retina, Na
+
/K
+
 ATPase from kidney, aquaporins from blood, and 
cytochrome oxidase from heart. Many prokaryotic membrane proteins and recently also 
eukaryotic membrane proteins have been successfully overexpressed in different pro- 
and eukaryotic expression systems, prokaryotic proteins in Escherichia coli and 
Lactococcus lactis and eukaryotic proteins in the yeasts Saccharomyces cerevisiae and 
Pichia pastoris, insect cells and in mammalian cell lines. The expression systems are 
sorted by increasing complexity with respect to the translation machinery, 
posttranslational modifications and lipid composition of the membrane. These factors 
have become important for functional expression of complex eukaryotic proteins. 
Membrane proteins are extracted from membranes by detergents. Detergents are 
amphiphilic molecules composed of a polar or charged head group and a single 
hydrophobic tail. They mimic the amphiphilic nature of the lipid membrane and are thus 
suited to cover the hydrophobic belt of the membrane protein. Due to their cone-like 
shape, detergents spontaneously form micelles in solution if the concentration is above 
the critical micelle concentration (CMC). These micelles surround the hydrophobic 
 
Fig 1-14 Characteristics of Amphiphiles 
Amphiphiles are composed of a hydrophilic head group (blue) and a hydrophobic tail (grey). Depending 
on the volume ratio of head group to tail of a monomer they occupy a cylindric shape (A; lipids) that 
results in a 2D layer or a cone shape (B; detergent) creating a globular micelle. The micelle formation 
starts at concentrations around the critical micelle concentration (CMC). 
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outside of the membrane protein and thus convert the previously insoluble protein into a 
soluble protein detergent complex (Fig 1-14B). The use of the appropriate detergent is 
critical for the purification process. They are chosen based on their ability to extract the 
protein in an active, homogenous and stable state. The solubilized detergent-protein 
complex is usually crystallized by standard methods. 
The crystallization process is little understood and is mainly a trial and error 
procedure. In this study initial crystallization conditions are obtained using robot 
screening of thousands of conditions in a vapor diffusion experiment. Promising 
conditions are subsequently refined by hand to obtain useful diffraction. In an 
alternative approach crystallization of membrane protein can also be achieved using a 
lipid environment like lipidic cubic phases, lipid sponge phases and bicelles instead of 
detergent micelles (Johansson, Wöhri et al. 2009). 
An important step towards the identification of well diffracting crystals is the 
modification of the protein construct and the modification of purification protocols to 
improve identified crystal forms. Such modification include the addition of lipids to the 
purification buffer, recloning of the protein to eliminate floppy parts, the increase of the 
thermo stability by introduction of single point mutations and the monitoring of the state 
of the protein during expression and purification by attachment of green fluorescent 
protein (GFP) (Geertsma, Groeneveld et al. 2008) (Kawate and Gouaux 2006). 
1.2.5 Motivation 
While transport properties of this important class of membrane proteins have been 
investigated during the last years, a thorough understanding of the structure-function 
relationship is still pending due to a lack of structural insights into this family. Until 
now the only available structural information comes from the prediction of membrane 
topology and secondary structure elements. The goal of this thesis is to establish the 
overexpression and purification of a prokaryotic CCC transporter as model system for 
structural and functional investigations to reveal first insight into the structural 
organization of the family. 
 
  
2 Results 
2.1 Overview 
The first stage in the process to obtain structural and functional information about a 
membrane protein is the production of functional and stable protein in large amounts. 
This process is accompanied by various challenges including mRNA stability, 
efficiency of translation and numerous posttranslational modifications of the protein. In 
later stages the homogeneity and stability of the protein in detergent solution poses 
challenges. To overcome these bottlenecks different strategies were combined (Fig 2-1). 
First, I have used established prokaryotic expression systems for overexpression of 
the target membrane proteins such as E. coli and L. lactis. Since different homologues 
of the same family have unique properties, I have included family members from 
diverse organisms that were identified by homology search within the microbial 
genomes. I have limited my efforts towards microbial proteins since these proteins do 
not contain certain characteristics of eukaryotic proteins that might prevent 
crystallization such as flexible loops, glycosylation sites and extra unstructured domains 
at the termini. The set of proteins chosen for overexpression and purification includes 
CCCs from prokaryotic extremophiles that are believed to contain very stable proteins 
that survive under extreme conditions, features that are believed to be beneficial for 
purification and crystallization. 
With the choice of E. coli and L. lactis as expression systems I cover Gram-negative 
and Gram-positive expression hosts. For the overexpression in E. coli I have used the 
strong lactose promoter system that controls expression of the T7 RNA-polymerase and 
the tunable arabinose promoter (pBAD) that directly allows the controlled expression of 
 
Fig 2-1 Pipeline Towards the Structure Solution of a Membrane Protein 
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the target protein. E. coli allows investigating the protein expression in a broad range of 
temperature, media and inducer concentrations, which might be beneficial for the 
production of functional protein. 
After overproduction of the membrane protein it must be extracted from the 
membrane to solution with detergent that mimics the natural environment of the protein 
in the hydrophobic membrane of the cell. The choice of the right detergent is the next 
challenge in the pipeline. Two constrains have to be fulfilled: The detergent must 
extract the protein from its membrane environment and it must stabilize the protein in 
 
Fig 2-2 Detergents 
Structures and properties of commonly used detergents in membrane protein research. 
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solution during the course of the experiment. Detergents differ in size and polarity of 
the head group and in the length of their hydrophobis tail (Fig 2-2). Nonionic detergents 
are mostly used for purification and crystallization, especially glycosides such as 
glucosides and maltosides that lead to the majority of successful structure solution of 
membrane proteins. 
Since the transporters are expressed as fusion proteins to a polyhistidine tag (His-
tag), the following purification steps include immobilized metal affinity 
chromatography (IMAC) and size exclusion chromatography (SEC) to produce clean 
and homogenous protein. SEC is additionally used to test the dispersity of the protein. 
All described parameters are crucial for the overexpression, purification and 
crystallization of prokaryotic members of the CCC family that will be discussed in 
detail in the following paragraphs. 
2.2 Homology Search 
During the last decade the number of sequenced microorganisms increased from a 
few to over thousand of genomes. This increase in genomic information offered the 
opportunity for extensive homology search for prokaryotic CCCs. The protein sequence 
of human NKCC2 was chosen as query for blast searches (blastp). The Blossum62 
matrix was used for the scoring of the alignments and all available microbial genomes 
at a time were chosen as query database. The first search at the beginning of this work 
pulled out 3 homologous proteins from the bacteria Cadidatus Protochlamydia 
amoebophila (CpCCC) and Synechococcus sp. (SynCCC), and the archaea 
Methanosarcina acetivorans C2A (MaCCC) (Tab 2-1). All three proteins share around 
30 % identical residues. Additionally four proteins were identified with lower homology 
(<25 %) (NAMES OF THE PROTEiNS). Due to the increasing size of the genome 
database the latest expression and purification trials included nearly 20 homologues. 
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The identified proteins were examined with respect to the homology to human 
NKCC2, taking their homology scores, identical and similar residues and the 
distribution/clustering of homologous regions as criteria. The overall very high amount 
of conservation is striking. Among prokaryotic membrane proteins often the sequence 
identity with their eukaryotic counterpart does not exceed 15 %. With a sequence 
identity of around 30 % and a sequence homology approaching 80 % in a pair-wise 
alignment to NKCC2 the conservation between pro- and eukaryotic CCCs is unusually 
high which makes it safe to propose that the prokaryotic proteins belong to the same 
Strain Strain code 
Identity 
[%] 
Similarity 
[%] 
Abbr. 
Length 
[aa] 
Gene 
Mw 
[kD] 
Homo sapiens - 100 - NKCC2 1099 SLC12A1 121.5 
Planctomyces 
maris 
DSM 8797 36 55 PmaCCC 732 
PM8797T_10
374 
80 
Syntrophobacter 
fumaroxidans 
MPBO 
DSM10017 34 52 SfCCC 733 Sfum_3620 80.5 
Salinibacter ruber DSM13855 30 51 SrCCC 754 SRU_2259 81 
Cyanothece sp. CCY0110 31 52 CyaCCC 746 EAZ91226 81.5 
Crocosphaera 
watsonii 
WH8501 31 52 CwCCC 744 EAM51764 81 
Psychromonas 
ingrahamii 37 
DSM17664 28 50 PiCCC 847 Ping_1733 93 
Trichodesmium 
erythraeum 
IMS101 31 52 TeCCC 744 Tery_1903 81 
Lyngbya sp. PCC8106 30 52 LyCCC 747 EAM34907 81 
Synechococcus sp. PCC7002 30 50 SynCCC 732 
SYNPCC700
2_G0123 
80 
Cadidatus 
Protochlamydia 
amoebophila 
UWE25 29 48 CpCCC 764 pc0822 84.5 
Methanosarcina 
acetivorans C2A 
DSM2834 31 47 MaCCC 758 MA4506 83 
Salinibacter ruber DSM13855 29 48 Sr2CCC 815 SRU_2257 87 
Tab 2-1 Prokaryotic Homologues 
List of 12 homologues with the best alignment properties (05-2009). The homologues were identified 
using blastp with Blossum62 matrix searching with NKCC2 (SLC12A1). Identity and similarity were 
determined in a pair-wise alignment with NKCC2. 
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family of proteins and share the overall fold and transport mechanism. The identified 
homologous proteins are distributed among archaea (MaCCC) and bacteria (e.g. 
PmaCCC, SfCCC, SrCCC). Cyanobacteria harbour the largest fraction of close 
homologues like CyaCCC and CwCCC. SfCCC and MaCCC are both derived from 
extremophiles which makes them interesting targets for structural investigations. The 
overall length of the bacterial transporters is around 750 amino acids which is about 350 
residues smaller than human NKCC2. This reduced length is a result of missing 
residues at the N-terminus of the protein as well as in loop regions between defined 
secondary structure elements. 
Upon colder inspection of the alignment interesting features become apparent which 
underline the conservation of functionally important regions (Fig 2-3). Following the 
cytoplasmatic N-terminal domain of NKCC2 12 highly conserved stretches of 18 to 22 
amino acids are found in the proposed transmembrane part of the protein. The predicted 
transmembrane spanning regions are interrupted by connecting loops that, in general, 
show lower conservation. Only the first intercellular loop, between transmembrane 
segment 2 and 3, is highly conserved. This loop is predicted to be essential for the ion 
 
Fig 2-3 Sequence Alignment of Selected Prokaryotic Homologues 
Human NKCC2 is aligned with the prokaryotic homologues PmaCCC, SfCCC, SrCCC, CyaCCC, 
CwCCC, PiCCC, TeCCC, LyCCC, SynCCC and MaCCC (from top to bottom). The numbering (above) 
corresponds to the residue number of human NKCC2. The coloring is according to conservation 
(red=identical residues, ruby=very homologues residues). The structural elements are labeled according 
to the prediction for NKCC2. The region of highest conservation is located within the transmembrane 
domains tm1-tm7 (blue box) and the first intracellular loop (loop2). Insertions in presumed loop regions 
within the transporters are visible between tm3 and tm4 as well as between tm5 and tm6. 
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transport by CCCs. In contrast to the large conservation in the membrane domain, the 
conservation in the C-terminal domain is moderate with 10-13 % of identical residues. 
2.3 Prokaryotic Full-Length CCC 
2.3.1 Cloning 
Samples of the selected microbes were purchased from various collections of 
prokaryotic organisms such as DSMZ, ATCC and PCC, a collection of cyanobacterial 
strains of the Pasteur Institute as dried cell pellets or growing cultures. The genomic 
DNA was subsequently isolated by standard procedures resulting in sufficient starting 
material for amplification. The genes of interests were amplified by the polymerase 
chain reaction (PCR), using primers that contain restriction sites for the subsequent 
cloning in expression vectors. The PCR protocol was adapted to take the differences in 
the nucleotide content into account. Besides variation of the PCR buffer composition 
the choice of the DNA polymerases (e.g. Vent®, Pfu®, Phusion® or mixures of 
polymerases as present in the Master Mix®) had the biggest influence on successful 
amplification. 
In the described work three different cloning strategies were pursued. The different 
gene products were cloned into E.coli expression vectors using either traditional Class II 
restriction enzymes, with overlapping, palindromic recognition and cutting sequences or 
fragment exchange cloning (FX cloning). To obtain expression constructs for L. lactis, 
vector backbone exchange (VBex) allowed the transfer of the gene of interest into a L. 
lactis expression vector. 
 
For cloning with ClassII restriction enzymes, a modified pET28b+ vector (Novagen) 
containing a 3C protease site sequence followed by a His-tag sequence at the 3‟ end of 
the gene was used (Fig 2-5A). The preferred 5' restriction sites were Nco1 and Nde1, 
which already contain a start codon, and 3' restriction sites like EcoR1 or Xho1. With 
this strategy no additional residues were introduced at the N-terminus of the produced 
protein. One drawback of this strategy is the use of two restriction enzymes for 
directional cloning of the amplified gene into the vector and the abundance of the 
respective restriction sequence in the gene of interests which prevents the use of specific 
enzymes in certain cases. 
To circumvent the problem of internal cleavage sites and to facilitate high throughput 
cloning efforts a different strategy was followed. FX cloning only uses one enzyme for 
directional cloning. As for the Gateway cloning system, the genes of interest and the 
target vector are mixed in one tube to which the enzyme is added. The enzyme 
catalyzing the reaction is very specific resulting in a low frequency of site in the genes 
of interest that could interfere with the procedure. 
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Another beneficial feature for high throughput cloning is the integration of the 
selection marker Ccdb in the original plasmid (Fig 2-4B). Ccdb is a cytotoxic protein 
that inactivates DNA gyrase and that is integrated into the plasmid under the control of 
a consecutive promoter (Bernard, Gabant et al. 1994). This cassette is eliminated after 
successful ligation with the insert. Thus relegations and uncut vectors are eliminated 
since bacteria containing such vectors fail to grow. N-terminal (pBXN3H) and C-
terminal (pBXGC3H) His10-tag fusions were constructed. This cloning method 
introduces an additional amino acid at the N-terminus of the protein (Fig 2-5B). 
 
L. lactis expression plasmids must be constructed differently with VBex since 
cloning in L. lactis is very laborious (Geertsma and Poolman 2007). The major 
manipulations are carried out in E. coli with an appropriate shuttle-vector that includes 
an origin of replication for E. coli (pREX). The first step is similar to the previously 
described FX cloning. In the second step the purified pREX plasmids of positive clones 
were mixed with a plasmid containing the essential replication elements for L. lactis 
(pERL). In the following reaction the vector-backbone exchange takes place. The 
mechanism is similar as for FX cloning but uses another enzyme Sfi1. Sfi1 has a freely 
designable cutting sequence of 5 bp that is surrounded by a 4 bp recognition sequence 
 
 
Fig 2-4 FX Cloning 
Fragment exchange (FX) cloning requires the addition of small DNA sequences on both sides to the gene 
of interest (blue). They differ in sequence to guarantee directional cloning. The target vector contains the 
CcdB marker (grey) flanked by the corresponding small DNA recognition sequences. After the cloning 
reaction 3bp are left on the plasmid introducing an additional amino acid on both sides (5` serin, 3` 
alanine). CcdB (grey) is a toxic protein to E. coli that prevents growing of false negative clones. 
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on each site. The two plasmids pREX and pERL have both two Sfi1 sites for directional 
cloning. During digestion of both vectors in the same tube, the religation and exchange 
of the vector fragments take place. A fraction of the generated plasmids combine the L. 
lactis origin of replication and selection marker with the gene of interest to create the 
resulting plasmid pNZ. The mixture is transformed into L. lactis by electroporation and 
cells that carry the correct plasmid are selected for by addition of antibiotics. In some 
cases of the constructs obtained by FX cloning a C-terminal fusion of green fluorescent 
protein (GFP) to the protein of interest was generated. In these fusion proteins the GFP 
portion can be used as folding indicator, for detection and quantification of the protein 
(see Fig 2-6). 
2.3.2 Expression Tests 
The identification of proteins with high expression levels and suitable biochemical 
properties is one of the critical steps towards structure determination. For that reason it 
was important to be able to broadly analyze the expression behavior of different protein 
constructs parallel and in low volumes. The expression tests were carried out with E. 
coli and L. lactis as expression hosts. The expression volume ranged from 1 ml in 96 
well plates to 5 ml in culture tubes. For comparison similar quantities of cells or isolated 
membranes were analyzed to correlate the amount of overexpressed protein for different 
protein constructs. In general 20 µg of total protein were analyzed corresponding to 
2 µg of total membrane protein. The two techniques for examining the expression level 
were anti His-tag Western blot analysis and the analysis of GFP fluorescence. The two 
methods are complementary and reveal different properties of the expressed proteins. 
For anti His-tag Western blot analysis a whole-cell extract is separated by SDS-
PAGE and the gel is blotted on a PVDF membrane following standard Western blot 
protocols. With this method all proteins that contain a N- or C-terminal His-tag fusion 
 
Fig 2-5 Expression Constructs for Prokaryotic Homologues 
The genes of interest (red) were cloned using different methods and constructs. A Cloning by ClassII 
restriction enzymes (cloning method 1) resulted in constructs with a C-terminal His-tag (top), or a C-
terminal His-tag separated from the protein by a 3C protease site (bottom). B Using FX cloning and 
FX/VBex cloning (cloning method 2 and 3) fusion proteins containing N- and C-terminal His-tags 
separated from the protein by 3C protease sites were generated (top and center). In certain constructs, 
GFP (green) was introduced at the C-terminus of the protein (bottom). FX cloning methods introduce an 
additional amino acid on the N-terminus of the protein (black box). 
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can be detected. A disadvantage of the method is the difficulty in the comparison of 
signals between different gels and the quantification of the signal for a correlation with 
the total amount of expressed protein. Additionally, no conclusions on the quality of the 
expressed protein can be drawn since misfolded or aggregated proteins are equally well 
recognized. To circumvent these limitations a sedimentation assay was included to 
remove aggregated protein and in that way to obtain information on the quality of the 
expressed material. After expression the cells were broken and membrane proteins were 
extracted by addition of detergent (typically 2 % DDM [w/v]). After centrifugation of 
the sample at high velocity (100000 x g) the amount of His-tagged protein in the 
supernatant was compared with the same protein before centrifugation. While well-
folded protein stays in the supernatant after high spin centrifugation, aggregated protein 
sediments faster and is usually found in the pellet. 
The sedimentation assay can be circumvented with the second protocol that makes 
use of GFP fluorescence (Geertsma, Groeneveld et al. 2008). For this assay fusion 
proteins that have GFP attached to the C-terminus of the protein of interest are used. 
The fluorescence properties of cell extracts that were separated on a SDS-PAGE gel 
were analyzed. Since GFP does not unfold under SDS-PAGE conditions, fusion 
proteins do in this case still show fluorescence. This method allows the quantification of 
the expressed protein levels and is thus suited for a direct comparison between different 
expression conditions and different homologues. Additionally, GFP that is fused to the 
C-terminus of the protein of interest can be used as folding indicator to detect the 
quality of the preceding protein. During translation GFP only folds and shows 
fluorescence if the preceding target protein is properly folded. If the protein, however, is 
misfolded and thus expressed in an aggregated form also GFP is misfolded and will not 
show any fluorescence. Well-folded protein in contrast allows proper folding of GFP 
and thus allows the quantification of the expression level by recording of its 
fluorescence. This method was applied for the measurement of in-cell GFP fluorescence 
in a 96 well plate format and for the measurement of on-gel fluorescence after SDS-
PAGE. This workflow opens the possibility for high through-put analysis of well-folded 
protein expression. 
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The combination of in-gel GFP fluorescence analysis and anti His-tag Western blot 
analysis of the same SDS-PAGE gel provides complementary information (Fig 2-6). 
Folded GFP connected to a SDS-denatured target-protein has a different migration 
behavior in SDS-PAGE than unfolded GFP fused to its target protein. The compact, 
folded GFP migrates faster than the misfolded protein and is thus separated from not 
properly folded material. After detection of the in-gel fluorescence signal the gel was 
further analyzed with anti His-tag Western blot. While in-gel fluorescence only shows 
the folded fraction of the GFP-tagged protein the Western blot detects both populations 
of the protein and thus allows the discrimination between well-folded protein (lower 
band) not folded protein (upper band). 
2.3.2.1 Overexpression of CCCs in E. coli Under the Control of the PBAD 
Promoter 
The use of the araBAD promoter offers an expression strategy that allows the tight 
regulation with a dose-dependent induction that combines gentle expression conditions 
with high expression yields. The inducer in this case is arabinose. In arabinose-free 
medium the AraC dimer binds two distant parts of the araBAD-operon and suppresses 
transcription through DNA loop formation. Upon arabinose binding the AraC dimer 
rearranges and binds to near parts of the araBAD-operon thus releases the loop and 
stimulates expression of the target gene. For this induction system E. coli strains that are 
incapable of metabolizing arabinose due to a disrupted ara gene such as TOP10 and 
MC1061 are available. MC1061 was the main cell line used for the described 
expression tests. The first constructs tested were prokaryotic homologues with C-
 
Fig 2-6 GFP as Expression and Folding Indicator 
Green fluorescent protein (GFP) can be used as folding indicator. A C-terminal GFP fusion to the protein 
is in the same state as the preceding protein during expression. If the preceding protein is folded, GFP is 
also folded and shows fluorescence. In contrast, if the preceding protein is aggregated, GFP is misfolded 
and lacks fluorescence. Since GFP keeps its conformation during SDS-PAGE analysis, it can be used to 
directly trace the folded fraction of the target protein within the gel (left). Since folded and unfolded GFP 
fused to SDS denature protein have different migration behaviors, they can be separated and thus used to 
analyze the ratio of folded (right, lower band) to aggregated protein (right, upper band) expression. 
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terminal GFP fusion followed by a His10-tag. The expression medium in these studies 
was Terrific broth (TB) with variation of arabinose concentration and temperature. 
The expression was analyzed by comparing in-gel GFP fluorescence and anti His-tag 
Western blot luminescence to judge the quality and quantity of expressed protein in 
dependence of expression conditions. 
First tests were performed using transformed E. coli MC1061 that were grown at 
37 °C to an OD600 nm=0.4, cooled down to 25 °C and induced with 10
-1
 to10
-5
 % (w/v) 
arabinose. After overnight growth at 25 °C the cells were harvested and equal amount of 
cells were analyzed. The expression of twelve different bacterial homologues of CCCs 
that contain C-terminal GFP fusions was investigated. The in-gel fluorescence showed 
that five out of twelve homologues, MaCCC, CpCCC, PmaCCC, PiCCC and SynCCC 
express well-folded protein with only minor degradation levels while the expression of 
the remaining seven homologues (CwCCC, LyCCC, CyaCCC, SrCCC, Sr2CCC, 
SpCCC, and SfCCC) was too low to proceed (Fig 2-7). The anti His-tag 
immunostaining revealed differences between the homologues. While the ratio of folded 
to misfolded protein is high for MaCCC, PmaCCC and PiCCC and somewhat for 
SynCCC. CpCCC showed a major fraction of misfolded protein that manifests itself as 
upper band on the Western blot (Fig 2-7). This homologue was nevertheless included 
for continuing investigations, since the amount of expressed protein was comparably 
high and since a variation of expression conditions might still improve the result. 
 
Fig 2-7 Analysis of Expression in E. coli Using GFP Folding Assay 
Homologues expressing in E. coli were selected for comparative analysis using the GFP folding assay. 
Expression was evaluated by in-gel GFP fluorescence (left panel) and anti His immunoblotting (right 
panel). Whole cell extracts corresponding to 20 µg total protein were separated via SDS-PAGE after cell 
lysis. Green triangles indicate well-folded fluorescent protein whereas red triangles mark misfolded, non 
fluorescent protein. Both analyses were performed using the same SDS-PAGE gel. 
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The constructs with high expression levels were selected for a fine-tuning of 
expression by varying the arabinose concentration and temperature. The protein quality 
and quantitiy was again monitored by GFP fluorescence and anti His-tag 
immunoblotting. MaCCC and CpCCC are shown as examples because both proteins 
show a different dependence on the inducer concentration and temperature (Fig 2-8). 
MaCCC showed a strong arabinose concentration-dependent expression behavior. The 
in-gel fluorescence signal increases with increasing arabinose concentration at 25 °C. In 
contrast at 17 °C the amount of expressed MaCCC stayed constantly low. For CpCCC 
the expression monitored by in-gel fluorescence stayed low at both temperatures. The 
analysis of expression using anti His-tag immunoblot illustrates the effect of 
overexpression on protein quality. MaCCC shows increasing expression of folded 
protein (lower band, green triangle) with higher inducer concentrations but additionally 
at high inducer concentration (10
-1
 % [w/v] arabinose) half of the expressed protein is in 
a misfolded state (higher band, red triangle). A concentration of 10
-2
 % [w/v] arabinose 
was thus the inducer concentration that was used for the scale-up of expressions 
cultures. CpCCC was mostly expressed as misfolded protein. While in-gel fluorescence 
still showed minor expression of folded protein at 25 °C the anti His-tag immunoblot 
revealed the highly aggregated state of the majority of expressed protein. 
 
Fig 2-8 Fine Tuning of Expression in E. coli 
MaCCC and CpCCC were expressed in E. coli with different temperatures and with varied arabinose 
concentrations of 10
-1
, 10
-2
, 10
-3
 % [w/v]. Whole cells equivalent to 20 µg of total protein were loaded 
after lysis and expression was analyzed with the GFP folding assay using GFP fluorescence (left panel) 
and anti His immunoblot (right panel). Green triangles correspond to well-folded, fluorescent protein 
whereas red triangles indicate non-folded protein. The weight is labeled corresponding to the marker (M). 
Both analyses were conducted using the same SDS-PAGE gel. 
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The overexpression CCC constructs with a C-terminal His-tag that lack GFP showed 
strikingly different results. The overall expression levels of the selected homologues 
were in general significantly lower and the sedimentation assay of detergent solubilized 
cells showed predominant expression of aggregated protein. Fine-tuning of the 
expression conditions by lowering the inducer concentration (e.g. 10
-2
, 10
-3
 and 10
-4
 % 
 
Fig 2-9 Expression Test in E. coli with N-terminal His-tag 
Expressing homologues (arrow) harboring an N-terminal His tag were analyzed using anti His 
immunoblot.  Equal amount of cells corresponding to 20 µg total protein were separated by SDS-PAGE. 
SrCCC showed strong degradation to lower molecular weight (dashed arrows).  
 
Fig 2-10 Expression of CCCs in E. coli with C-terminal His-tag Followed by Detergent 
Sedimentation Assay 
SrCCC and SynCCC were expressed in E. coli with a C-terminal 3C site and a His10-tag at different 
arabinose concentrations. Analysis of expression was performed by extraction of membrane proteins after 
cell lysis in 2 % DDM followed by a high-spin centrifugation. Solubilized cells (S) and supernatant after 
centrifugation (C) were analyzed by anti His-tag Western blot. The protein band is indicated by an arrow. 
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[w/v] arabinose) resulted in the expression of low quantities of well-folded protein as 
judged from the fraction of the protein in the supernatant after high spin centrifugation 
(Fig 2-10). Among the GFP-less constructs only PiCCC and SynCCC showed 
reasonable expression of well-folded protein. 
Besides proteins constructs carrying a C-terminal His10-tag also constructs with a 
His10-tag fused to the N-terminus of the protein were investigated. MC1061 E. coli cells 
containing CCCs with N-terminal His10-tag were grown at 37 °C, induced by addition 
of 10
-3
 % [w/v] arabinose and incubated overnight at 25 °C. Equal amounts of cells 
were loaded on SDS-PAGE and analyzed by anti His-tag Western blot. The in-gel 
fluorescence analysis is not applicable in this case since these constructs lack a C-
terminal GFP fusion as folding indicator. SrCCC exhibited strong overexpression while 
two transporters, PiCCC, and Sr2CCC were moderately expressed (Fig 2-9). Among the 
proteins that showed high expression, SrCCC was heavily degraded with a major band 
at lower molecular weight. All other proteins were very little or not overexpressed at all 
Homologue 
Expression 
strain 
Expression level PBAD 
N-His         C-His        C-His GFP 
PmaCCC MC1061 - + +++ 
SfCCC MC1061 - - - 
SrCCC MC1061 +++ * + - 
CyaCCC MC1061 + - ** - 
CwCCC MC1061 - - + 
PiCCC MC1061 ++ ++ +++ 
TeCCC MC1061 - - - 
LyCCC MC1061 + - + 
SynCCC MC1061 - ++ ++ 
CpCCC MC1061 - - - ** 
MaCCC MC1061 + ++ +++ 
Sr2CCC MC1061 ++ - ** + 
Tab 2-2 Summary of Expression Tests in E. coli Using the Arabinose Induction System 
The prokaryotic homologues tested for expression are listed with their expression behavior in E. coli. N-
terminal His-tag fusion (N-His), C-terminal His-tag fusion (C-His) and C-terminal GFP and His-tag 
fusion (C-His GFP) were analyzed. The expression was classified to good (+++), medium (++), low (+) 
and no (-) expression. Some homologues showed degradation (*) and others could not be solubilized 
during detergent sedimentation assay (**). 
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and thus not further analyzed. 
2.3.2.2 Expression in E. coli with T7 promoter 
Beside the expression efforts of prokaryotic CCCs under the control of the PBAD 
promoter I have also investigated the expression under the control of the conventional 
PLAC promoter. By using the T7 expression system present in pET vectors from 
Novagen, the gene of interest was inserted behind the very strong promoter from E coli 
bacteriophage T7. In the absence of T7 polymerase the promoter is turned off. The 
strains used for expression contain a single copy of T7 polymerase in their genomic 
DNA (DE3) under the control of a Lac-UV5 lac promoter. This promoter is turned off 
as long as the lac repressor (LacI) is bound to the operator. After dissociation of LacI 
through binding of lactose or IPTG from the operator the transcription and translation of 
T7 polymerase starts and the expression of the gene of interest begins. Since the lac 
promoter is leaky, basal expression level of T7 polymerase in the absence of inducer 
always leads to low expression of the protein of interest. Additionally, the expression is 
always strong in the presence of inducer without the possibility of regulation by a 
variation of inducer concentration. The main parameters screened during expression 
tests were thus temperature, media composition, expression time and the choice of the 
E. coli expression strains. The temperature was varied to investigate the effect of the 
cell metabolism on the expression behavior, since lower temperatures slow down the 
growth of the cells and thus decrease protein expression. The protein translation 
machinery thus has more time for correct membrane insertion and folding. Expression 
was screened at temperatures of 20 °C, 30 °C or 37 °C. The investigated media include 
standard LB medium, rich TB medium, minimal M9 medium and autoinduction 
medium (for details see materials and methods). The first three media differ in their 
richness, meaning amount and type of the carbon source and nitrogen content. TB 
medium and M9 medium are additionally buffered to maintain the pH during 
expression. The cells in all three media were induced by IPTG. In autoinduction 
medium the induction is triggered by a glucose/lactose mixture that regulates expression 
metabolically. As long as glucose is still present in the medium it supports the 
repression of the lac promoter since it decreases the cAMP level, which prevents the 
binding of the transcriptional activator catabolic activator protein (CAP). After glucose 
is metabolized by the growing cells, lactose as primary carbon source is imported which 
in turn slowly induces expression by binding to the repressor protein LacI. 
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Several investigated homologues showed detectable yields when expressed under the 
control of the T7 promoter. For two of the expressed transporters, the homologues 
SynCCC and MaCCC, the use of autoinduction medium significantly increased the 
expression compared to standard LB medium (Fig 2-11). This increase multiplied the 
yield of expressed protein by at least one order of magnitude. The temperature for 
optimal expression was found to be best at 30 °C. 
After this initial test a time course was performed to analyse the progress of 
expression for MaCCC and SynCCC. This time series revealed an expression of 18 to 
20 h as optimal. At 37 °C the highest relative expression was also reached after 18-20 h 
but the yield was lower than at 30 °C. 20 °C was included in the tests to investigate, 
whether longer expression increases the amount of protein. After 26 h at 20 °C weak 
expression was detected that was several orders below the yield of expression at 30 °C. 
A temperature of 30 °C with a growing time of 18-20 h was thus chosen for scale-up 
expression for subsequent purification (see next chapter). 
 
Fig 2-11 Expression Test in E. coli Using Different Media 
MaCCC and SynCCC were tested for expression in different media using the E. coli strain BL21 (DE3). 
After cell lysis using 5 M urea 20 µg total protein were loaded per lane and detected with anti His 
Western blot. Cultures growing in LB at 37 °C to OD600nm=0.5 and induction with 0.2 mM IPTG at 20 °C 
overnight were compared to culture growing at different temperatures overnight (37 °C, 30 °C, 20 °C) 
using autoinduction media. 
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Beside MaCCC and SynCCC, another homologue, SfCCC, showed high expression 
in TB medium at 37 °C when induced with 0.2 mM IPTG for 3 h at 37 °C. This 
homologue expresses about ten times more than MaCCC expressed in autoinduction 
medium. Several other homologues also showed decent expression levels at standard 
conditions illustrated in table Tab 2-3 .From the expression tests no information was 
obtained whether the protein is folded and indeed several of the homologues turned out 
to be not stable in detergent solution after purification, which will be described in a later 
chapter. 
2.3.2.3 Expression in L. lactis 
Analogous to the expression under the control of the PBAD promoter the heterologous 
overexpression of all prokaryotic CCCs was tested in the Gram-positive bacterium L. 
lactis under the control of the PNIS promoter. The parameters for tuning L. lactis 
expression are not as broad as for E. coli, besides the variation of the inducer nisin, a 
peptide of 34 amino acids, that is produced by L. lactis itself. L. lactis is sensitive to the 
growth medium (it grows best in M17 medium) and has a narrow temperature window. 
The temperature ranges between 20 °C with very high doubling time to a maximum of 
30 °C. Initial expression tests were carried out at 20 °C overnight and induction with  
10
-3
 % [v/v] of nisin.  
Homologue Expression strain condition Expression level T7 
SfCCC BL21 TB, 37/25 °C o/n +++ 
SrCCC BL21 TB, 37/25 °C o/n +++ 
CyaCCC BL21 TB, 37/25 °C o/n +++ 
CwCCC BL21 TB, 37/25 °C o/n +++ 
PiCCC BL21 TB, 37/25 °C o/n +++ 
TeCCC BL21 TB, 37/25 °C o/n +++ 
LyCCC BL21 TB, 37/25 °C o/n +++ 
SynCCC BL21 Auto, 30 °, o/nC ++ 
CpCCC BL21 TB, 37/25 °C o/n - 
MaCCC BL21 Auto, 30 °C ++ 
Tab 2-3 Overview of Expression Using T7 Promoter in E. coli 
Homologues were expressed in E. coli using BL21 (DE3) cells at the indicated condition. The expression 
level was classified as good (+++), medium (++), low (+) and none (-). 37/25°C o/n = growing at 37 °C to 
an OD600nm=0.5 and induction with 0.2 mM IPTG at 25 °C overnight. Auto = autoinduction media 
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Like in the case of the PBAD promoter, the expression of C-terminal GFP fusion 
products was monitored by recording GFP fluorescence. The in-gel GFP fluorescence 
showed strong signals for CyaCCC, PmaCCC and PiCCC. Lower fluorescence was 
recovered for CwCCC, MaCCC and SrCCC. In no cases degradation was observed 
during expression. In-gel fluorescence of whole cell samples showed additionally to the 
protein of interest three bands from endogenous L. lactis proteins (Fig 2-12, dashed 
arrow). 
The anti His-tag immunostaining showed additional bands of slower migrating 
protein, which, in contrast to E. coli , in L. lactis are not indicative for misfolded protein 
(Fig 2-13). Besides the expression of C-terminal GFP fusion proteins, all CCCs were 
also investigated with a N-terminal His-tag. Selected samples of transporters are shown 
for comparison in Fig 2-13. SrCCC showed strong expression as N-terminal His-tag 
construct. Other homologues like CwCCC, MaCCC, PmCCC and PiCCC did either not 
express or expressed very little. 
 
Fig 2-12 Analysis of Expression in L. lactis with In-Gel GFP Fluorescence 
Selected homologues expressing in L. lactis were comparatively analyzed with in gel GFP fluorescence. 
Whole cell extracts were analyzed after cell lysis. 10 µg of total membrane protein was loaded on each 
lane. Both N- and C-terminal His-tag constructs were included. The green triangle indicates the position 
of the GFP fluorescence signal. The N-terminal fusions (first 5 lanes) lacking GFP served as control for L. 
lactis proteins showing fluorescence (dashed arrows). 
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2.3.2.4 Conclusions of the Expression Tests 
 
 
Fig 2-13 Analysis of Expression in L. lactis with Immunostaining 
Selected homologues expressing in L. lactis were comparatively analyzed with anti His-tag immunoblot. 
Whole-cell extracts containing 10 µg total membrane protein were loaded after cell lysis. Both N- and C-
terminal His-tag constructs were analyzed. The green triangle indicates the position of the GFP 
fluorescence signal (seeFig 2-12). 
Homologue Expression strain condition Expression level pNZ L. lactis 
   N His C His 
CyaCCC  30 °C - + 
MaCCC  30 °C - + 
PmaCCC  30 °C - ++ 
PiCCC  30 °C - +++ 
SrCCC  30 °C +++ ++ 
CwCCC  30 °C - + 
LyCCC  30 °C - - 
SfCCC  30 °C - - 
Tab 2-4 Overview of the Expression Tests in L. Lactis 
The expression level in L. lactis using a N-terminal His-tag or a C-terminal His-tag and GFP fusion 
classified as high (+++), medium (++), low (+) and minor or absent (-). These classifications are relative 
to the expression of the other homologues. 
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After extensive screening for expression conditions for twelve prokaryotic CCCs, 
some proteins could be identified as potential targets for scale-up and purification. Most 
of the homologues showed expression in E. coli under the control of the lac-T7 
promoter system. This could have various reasons: The T7 promoter is a very strong 
promoter, that is continuously transcribed and might in that way foster the 
overproduction of proteins. The initial tests with the T7 system didn`t allow to conclude 
on the quality of the expressed material. The pBAD plasmids used with a C-terminal 
GFP fusion gave the opportunity to also assay the quality of the produced material. 
Most of the expressed proteins in this system were well-folded or contained a major 
fraction of folded material. 
The use of L. lactis as different expression host showed in general lower expression 
but allowed the identification of 2 additional proteins, CyaCCC and SrCCC whose 
investigation was pursued. 
Homologue T7 pBAD-N pBAD-C pNZ 
PmaCCC - - +/+++ -/++ 
SfCCC +++**  -/- -/- 
SrCCC +++** +++* +/- +++/++ 
CyaCCC +++** + -**/- -/+ 
CwCCC +++** - -/+ -/+ 
PiCCC +++** ++ ++/+++ -/+++ 
TeCCC +++** - -/- -/- 
LyCCC +++** + -/+ -/- 
SynCCC ++ - ++/++ -/- 
CpCCC - - -/-** -/- 
MaCCC ++ + ++/+++ -/+ 
Sr2CCC +++** ++ -**/+ -/- 
Tab 2-5 Summary of the Expression Test in E. coli and L. Lactis 
The prokaryotic homologues tested for expression are listed with their expression behavior in E. coli. 
Using the T7 promoter only C-terminal His-tags are listed, for PBAD the N-terminal tag (pBAD-N) and the 
C-terminal tag (pBAD-C) including only His-tag or with GFP (x/x). The expression in L. lactis I 
indicated for N- and C-terminal tag (x/x). The expression was classified to good (+++), medium (++), low 
(+) and no (-) expression relative to each other in the used expression system. Some homologues showed 
degradation (*) and others could not be solubilized during detergent sedimentation assay (**). 
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The broad screening of expression condition reduced the choice of possible proteins 
for scale-up and purification from twelve to five. In the next step, the biochemical 
characterizations of the transporters will decreases the pool of suitable candidates 
further. The following chapter describes the biochemical characterization of the 
preselected CCCs with respect to their extraction behavior and stability in different 
detergents. The major quality check during extraction and purification was SEC elution 
profile. The GFP fluorescence was used for detection of appropriate constructs. The 
different behavior during extraction and purification will be discussed in detail for the 
selected homologues MaCCC, SfCCC and SynCCC. MaCCC was the homologue with 
the most promising behavior and was thus most thoroughly characterized. 
2.3.3 Purification of Prokaryotic CCCs 
The purification of membrane proteins starts with the extraction of the protein from 
the membrane with various detergents (Fig 2-2). After successful solubilization of the 
His-tagged protein the purification proceeds by immobilized metal affinity 
chromatography (IMAC), and optional removal of the His-tag by limited proteolysis at 
an introduced protease cleavage site and size exclusion chromatography (SEC). 
IMAC takes advance of the chelating properties of Me2+ ions. The C-terminally 
fused His6-tag or His10-tag can bind to Ni
2+
, Co
2+
, Fe
2+
 and Zn
2+
 ions with decreasing 
affinity. Thus protein can be retained on Me
2+
 chelating matrix. Different resins with 
varying properties were used during this study: Ni-NTA (Quiagen), Co-Talon 
(Clontech), Ni-, Co-, Fe-, Zn-sepharose (Amersham) and Ni-IDA (Macherey-Nagel). 
Additionally the binding properties of the protein vary depending on the buffer 
composition, tag accessibility and tag length. Imidazole, which mimics the side chain of 
histidine, is a competing agent for protein binding and is used for the removal of non-
specifically bound proteins at lower concentrations and the elution of the protein from 
the resin at higher concentration. To determine the boundaries for optimal washing and 
elution of the protein a step gradient of different imidazole concentrations was used. 
For continuing analysis, the His tag was removed from the protein by limited 
proteolysis using the 3C precision protease that cleaves a 10 residue long recognition 
sequence that was introduced between the protein and the tag (Fig 2-14). The cleavage 
removes the flexible His-tag, which is usually beneficial for crystallization. Moreover, 
 
Fig 2-14 3C Protease Site 
The protein of interest (red) is followed by a protease site and the His-tag (grey). After digestion with 3C 
protease (blue) six residues remain on the protein as short C-terminal tail. 
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since the His-tag is partially charged at neutral buffer conditions it might interfere with 
the formation of crystallization contacts. After cleaving of the tag a tail of six residues 
remain attached to the C-terminus of the protein. 
The most important tool in this study to examine the mono-dispersity and oligomeric 
behavior of the purified transporter was size exclusion chromatography. From this 
technique the distribution of oligomeric states of the protein and the amount of 
aggregation can be derived in a simple straightforward manner. Additionally SEC offers 
the possibility to separate impurities with very different molecular weight from the 
target protein. 
SEC separates the proteins based on their size and shape. A calibration curve was 
recorded with known protein standards to obtain the relationship between molecular 
weight and the retention volume of the column (Fig 2-15). With the assumption of 
globular proteins, the molecular weight for the tested protein can be estimated. Since 
membrane proteins are surrounded by a detergent micelle (protein detergent complex, 
PDC) in solution their apparent molecular weight is higher than expected for protein 
alone because of the contribution of the detergent. 
 
 
Fig 2-15 Calibration Curve of S200 GE Healthcare Column 
The S200 column used in this study was calibrated using standard molecular weight markers. The 
retention volume was measured on an Äkta Prime purification system that was used for all purifications.  
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2.3.3.1 SfCCC 
For scale-up SfCCC was expressed under different conditions to maximize the 
expression level and the fraction of extracted protein. The protein was expressed under 
the control of the T7 promoter. Due to low expression in autoinduction media (which 
gave optimal expression for MaCCC) SfCCC was expressed in TB media (20 °C o/n, 
28 °C o/n and 37 °C for 3 h). Additionally the inducer concentration varied between 
0.25 to 1 mM IPTG. At strong induction conditions (1 mM IPTG, 37 °C) SfCCC was 
mostly found in the pellet after solubilization and high spin centrifugation. Only Fos-
cholin 12 could extract a minor fraction from the membrane and keep it in solution (Fig 
2-16A). With the shift to milder expression conditions (0.5 mM IPTG, 20 °C, o/n) the 
expression was improved. Fos-cholin 12 was able to extract most and Fos-cholin 14 
about 30 % of the protein (Fig 2-16B). The choice of these two detergents in 
combination with the milder expression conditions were thus used to proceed with 
purification.  
Since Fos-cholins are very potent detergents the initial solubilization concentration 
of 2 % (w/v) was decreased to 0.25-0.5% (w/v). The following IMAC purification on 
Ni-NTA agarose in Fos-cholin 12 using the His10-tag was initiated with batch binding in 
the presence of 15mM imidazole. The resin was subsequently washed on column with 
50mM imidazole and the bound protein was eluted with 300mM imidazole. SfCCC 
showed a small amount of leakage during washing and could be recovered in a very 
 
Fig 2-16 SfCCC Extraction Tests in Dependence of Expression Conditions 
SfCCC was expressed at different temperatures and inducer concentrations. After preparation of the 
membranes from expression cultures at conditions listed below the panel, samples were incubated with 
2 % of the indicated detergent followed by high-spin centrifugation. Pellet (P) and supernatant (S) of the 
centrifugation were analyzed by SDS-PAGE and anti His-tag Western blot to quantify the extraction 
efficiency. A SfCCC was expressed at 37 °C and induced with 1 mM IPTG for 3 h. Only with Fos12 a 
minor fraction could be extracted from the membranes. B With expressing SfCCC at 20 °C overnight and 
induction with 0.5 M IPTG most of the protein could be extracted with Fos12 and half with Fos14. DM, 
decyl maltoside; DDM, dodecyl maltoside; Fos12, Fos-cholin 12; LDAO, lauryl dimethylamine n-oxide; 
OG, octyl glucoside; Fos14, Fos-cholin 14 
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pure state in the elution fraction (Fig 2-17D). The His10-tag was successfully removed 
by incubation with 3C protease, and the following SEC using a S200 column showed a 
peak at 11.3 ml elution volume, which corresponds to a molecular weigth of 290 kD 
that would hint at an oligomeric state higher than a monomer (Fig 2-17A). A significant 
amount of the protein was eluting in the void volume of the SEC column (arrow) 
indicating the presence of higher molecular aggregates. This presence of higher 
oligomers could indicate instability of the protein or could also be due to Fos-cholin 12 
extracting previously misfolded protein from the membrane. The stability of SfCCC 
over time (1 and 5 days) was investigated by reinjection of the main SEC elution peak 
at later time points. Since the reinjected protein did not show aggregation, it can be 
concluded that it is reasonable stable in detergent solution (Fig 2-17B and C). The 
elution volume stayed constant over time indicating that the oligomeric assembly did 
not change over time.  
 
Fig 2-17 SfCCC SEC in Fos-cholin 12 
SfCCC was purified in Fos-cholin 12 with 
IMAC using a 10His tag and injected onto a 
S200 SEC column. The arrow is indicating 
the void volume (A-C). (A) First SEC with an 
elution volume of SfCCC at 11.3 ml and 
higher molecular aggregates at the void 
volume. The analyzed fractions are indicated. 
(B) Reinjection of the peak fraction 5 from 
[A] after 1 day and monodispers elution at 
11.4 ml. (C) Reinjection of the peak fraction 
5 from [A] after 5 days and elution at 11.3 ml 
with a slight shoulder. (D) SDS-PAGE of the 
IMAC and SEC fraction from [A] and silver staining. SfCCC band is indicated by an arrow. The protein 
shows a clean elution from the IMAC column [elu] and clean SEC appearance. The IMAC 50 mM 
2 Results 
42 
imidazole wash caused minor leakage of SfCCC [w1,w2]. The retention volume indicated in [ml] is 
plotted against the absorption at 280 nm 
 
The stability of SfCCC in different detergents was investigated by dialysis of the 
main protein peak after SEC of protein purified in Fos-cholin 12. Aliquots of the protein 
were dialyzed overnight at 4 °C into the detergents DM, DDM, LDAO, C12E9 at a 
concentration exceeding 2 times the respective CMC. After dialysis the samples were 
subjected to SEC with the column equilibrated with running buffer containing solely the 
new detergent. The detergent exchange experiments revealed that SfCCC is instable in 
most investigated detergents. Only DM and LDAO allowed the recovering of a 
significant part of the protein at a symmetric elution peak (Fig 2-18). In all tested 
detergents the formation of high molecular aggregates was observed. In DDM the 
aggregates overlap with the main elution peak. C12E9 was not tested by gel-filtration 
because the protein precipitated during overnight dialysis. The retention volume of the 
main peak shifted during the detergent exchange by up to 1 ml from 11.3 ml to 12.2 ml 
(DM). This shift in the molecular weight (which corresponds to n apparent change in 
the molecular weiht of 185 kD) could either be due to a change in the micelle size or it 
could indicate a change in the oligomeric state of the protein. 
In summary, SfCCC could be expressed using the T7 promoter with a high yield, 
while the expression under the control of the PBAD promoter was unsuccessful. 
Biochemical investigations identified detergents of the Fos-cholin family to be the only 
detergents suitable for extraction of SfCCC from the membranes. After separating high 
 
Fig 2-18 SfCCC Detergent Stability Screen 
After purification of SfCCC with the detergent Fos-cholin 12 including IMAC and SEC the main peak 
fraction was dialyzed overnight in different detergents. A SEC with the new detergent using a S200 
column followed. In DM and DDM the protein showed moderate stability with high molecular aggregates 
also in the void volume (arrow). In LDAO the protein was more stable without heavy aggregation. 
Overall the elution volume increased up to one milliliter compared to the Fos-cholin 12 elution hinting for 
a oligomeric rearrangement to a monomer. C12E9 showed heavy precipitation and was not tested on SEC. 
The retention volume indicated in [ml] is plotted against the absorption at 280 nm. 
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molecular aggregates with SEC the main elution peak, corresponding to a putative 
dimeric transporter, was found to be stable in solution. Despite an overall promising 
behavior crystallization trials of SfCCC in the presence of Fos-cholin 12 and 14 , DM, 
DDM and LDAO and with the addition o lipids didn't show crystalline behavior. 
2.3.3.2 SynCCC 
SynCCC was one of the first proteins that could be identified using a blastp search at 
the beginning of the thesis in 2002. The first expression trials were carried out in 
parallel with MaCCC and the expression in E. coli growing in autoinduction media 
overnight at 30 °C was identified to yield the highest amounts of protein. The extraction 
from isolated membranes showed Fos-cholin 12 and 14 to be the only detergents that 
efficiently solubilize SynCCC.  
The first purifications of SynCCC were conducted using the C-terminal His6-tag for 
IMAC. After batch binding to Ni-NTA agarose resin and washing in the presence of 
15 mM imidazole the protein was eluted with 300 mM imidazole. The following SEC 
showed a characteristic elution profile that indicates the presence of different defined 
oligomers. After a small fraction of aggregated protein (arrow) eluting after the void 
volume the main elution consisted of a double-peak with elution volumes of 10.8 ml 
and 11.5 ml corresponding to an apparent molecular weight of 370 kD and 260 kD, 
 
Fig 2-19 SynCCC SEC Behavior and Stability Test in Fos-cholin 12 
SynCCC was purified using Fos-cholin 12 and subjected to SEC on a S200 column. The retention 
volumes are indicated in [ml] and the void volume by an arrow. (A) First injection after IMAC 
purification and cleavage of the His-tag. SynCCC eluted as double peak with elution volumes of 10.8 and 
11.5 ml. A reinjection of both elution peaks 24 h later resulted in the predominant elution at higher 
volume ([A]-10.8 ml in (B); [A]-11.5 ml in (C)). The retention volume indicated in [ml] is plotted against 
the absorption at 280 nm 
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respectively (Fig 2-19A). After reinjection of fractions of the two peaks a single 
monodisperse peak at a higher volume was recovered (Fig 2-19B and C).  
A broad crystallization screen with both peaks in Fos-cholin 12 did not show any 
hints of crystallization. 
In a second expression strategy using the PBAD expression system combined with a 
C-terminal GFP fusion the expression of SynCCC was optimized for maximum 
expression of well-folded protein. Nevertheless the yield of purified protein after 
expressing overnight at 25 °C with an induction of 0.0001 % [w/v] arabinose was still 
lower than the expression obtained using the T7 promoter. Interestingly SynCCC after 
optimized PBAD expression showed a different extraction behavior compared to the 
expression with the T7 promoter since the protein was now extractable in DDM. 
SynCCC containing a His10-tag was purified in DDM by binding to Ni-NTA in batch in 
the presence of 15 mM imidazole. The protein was washed with 50 mM imidzole and 
eluted with 300 mM imidazole. The following SEC using a S200 column is partly 
aggregated but otherwise showed a single peak at 11.3 ml (Fig 2-20A). The elution 
volume corresponds to a molecular weight of 290 kD, which indicates a dimeric 
behavior. The aggregates could be successfully removed by SEC and a reinjection of the 
 
Fig 2-20 SynCCC SEC Behavior and Stability 
SynCCC was purified in DDM with IMAC using the His10-tag. Before injection onto a S200 column the 
C-terminal His-tag was removed. The retention volume is indicated in [ml]. (A) The SEC chromatogram 
showed an elution at 11.3 ml corresponding to molecular weight of a dimer. Additionally heavy 
aggregation could be observed eluting right after the void volume (arrow). (B) Reinjection of the main 
elution peak of [A] 24 h later. A stable dimer was recovered (11.2 ml) with little aggregation tendency. 
The retention volume indicated in [ml] is plotted against the absorption at 280 nm 
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main elution peak preserved the apparent dimeric behavior of the protein (Fig 2-20B). 
Although the protein expressed under the control of the PBAD promoter showed an 
improved detergent stability, crystallization trials in DDM (with and without addition of 
lipids) were unsuccessful. 
SynCCC could be expressed under the control of two different promoters. When 
expressed with the T7 promoter system in BL21 (DE3) cells, the protein could only be 
extracted and purified in Fos-cholin 12. The SEC showed two overlapping peaks 
indicating two stable oligomeric species. Expression with the PBAD promoter in 
MC1061 cells in contrast generated a protein that was extractable in DDM. A 
symmetric, monodisperse peak could be recovered after reinjection. Both preparations 
did not show any sign of crystallization. 
2.3.3.3 MaCCC 
Similar to SynCCC MaCCC previously showed promising expression behavior in 
both E. coli promoter systems T7 and PBAD. After expression under the control of the T7 
promoter in autoinduction medium the solubilization of the protein from isolated 
membranes in different detergents was investigated. A broad set of detergents was 
chosen, which was widely used for purification and crystallization including the 
maltosides with different chain length, DM and DDM, LDAO, C12E9 and Fos-cholin 12. 
 
Fig 2-21 MaCCC-His6 IMAC Purification Test 
After batch binding of DM solubilized MaCCC (with a His6-tag) to equilibrated Ni-NTA a stepwise 
imidazole gradient was performed to investigate the elution properties and thus determine the maximal 
washing concentration. (A) Anti His-tag Western blot analysis of the wash fraction with 10, 15, 20, 40, 
and 60 mM Imidazole. The elution of MaCCC (arrow) already started at 15 mM and is dominent at 
40 mM imidazole. (B) SDS-PAGE analysis and coomassie stain of the 15 mM wash fraction and the 
300 mM imidazole elution fraction. At 15 mM little MaCCC (arrow) leaked and at 300 mM. MaCCC is 
the major protein band. 
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The supernatants and the pellets after high-speed centrifugation were analyzed with 
SDS-PAGE followed by anti His-tag immunoblotting that showed DM and Fos-cholin 
12 to have the best extraction properties. 
DM solubilized MaCCC was used for the subsequent purification steps. For 
MaCCC-His6, Ni-NTA showed the best binding properties. A step gradient from 0 mM 
to 60 mM imidazole controlled by anti His-tag Western blot indicated 15 mM imidazole 
to be the limiting concentration for washing the resin without losing significant amount 
of target protein (Fig 2-21A, arrow). The protein was eluted with 300 mM imidazole 
and analyzed by SDS-PAGE. Even though many impurities could be removed during 
washing a significant amount of impurities is still present in the elution fraction (Fig 
2-21B). 
To improve the binding of MaCCC to resin and thus enhance the purity of the 
sample, MaCCC was fused to a C-terminal His10-tag. A His10-tag binds stronger to Ni-
NTA and thus allows more stringent washing steps, which result in cleaner protein after 
elution. A step-gradient after batch binding of MaCCC-His10 to Ni-NTA of 10 mM to 
60 mM imidazole allowed washing off most impurities. The protein eluted at 300 mM 
imidazole. During washing with 60 mM imidazole the protein did not eluted from the 
 
Fig 2-22 MaCCC-His10 IMAC Purification Test 
After batch binding of DM solubilized MaCCC (with a His10-tag) to equilibrated Ni-NTA a stepwise 
imidazole gradient was performed to investigate the elution properties and thus determine the maximal 
washing concentration. (A) Anti His-tag Western blot of the wash fractions with 0, 10, 20, 40 and 60 mM 
imidazole. At 0 mM only residual MaCCC from column loading was washed off. MaCCC eluted at 
300 mM (arrow). The cleaved C-terminal domain still harboring the His-tag was co-purified (dashed 
arrow). (B) SDS-PAGE analysis and coomassie stain of the 50 mM wash fraction and the 300 mM 
imidazole elution fraction. At 50 mM most of the impurities were washed out to obtain a very clean 
300 mM imidazole elution fraction of MaCCC (arrow). 
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Ni-NTA resin and could thus be quantitatively recovered with the high-imidazole 
elution (Fig 2-22A arrow). The domain of MaCCC was cleaved from the full-length 
protein and a fraction of the molecules was co-purified since it still contained a His-tag 
on its C-terminus (dashed arrow). The use of a His10-tag for purification in binding to 
Ni-NTA affinity resin thus showed a major improvement in purity compared to 
MaCCC-His6 (Fig 2-22B). 
After IMAC purification the eluted protein was incubated for 2h at 4 °C with 3C 
protease at a molar ratio of 1mol of protease per 5 mol of protein. After this step a 
complete removal of the His tag was confirmed by the absence of an anti His-tag signal 
in a Western blot of MaCCC. Size exclusion chromatography was used to gain 
information about the homogeneity of the protein sample in solution. MaCCC was 
subjected to SEC using a S200 sepharose column. Runs at either 4 °C or 20 °C in the 
presence of DM were carried out to evaluate the stability at these temperatures. At 4 °C 
the size exclusion chromatogram tracing the absorbance at 280 nm showed an elution 
 
Fig 2-23 MaCCC SEC Profile 
Purification of MaCCC in DM with a S200 SEC column. The void volume is indicated by an arrow. (A) 
At 4 °C MaCCC eluted at 11.9 ml which corresponds to an apparent molecular mass of 200 kD with 
minor aggregation at the void volume (arrow). At a volume of 14.6 ml the soluble C-terminal domain 
eluted which was co-purified as degradation product of the full-length MaCCC. (B) At room temperature 
a large aggregation peak at the void volume was visible (arrow). With the elution volumes of 10.9 ml and 
11.9 ml an apparent molecular weight of 350 kD and 200 kD, respectively was observed. At a volume of 
14.6 ml the soluble C-terminal domain eluted which was co-purified as degradation product of the full 
length MaCCC. The retention volume indicated in [ml] is plotted against the absorption at 280 nm 
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peak at a volume of 11.9 ml (Fig 2-23A). This retention volume corresponds to the 
calculated mass of around 200 kD. Minor absorption was detected at the void volume 
where high molecular aggregates elute. 
The purification at 20 °C in DM revealed a different behavior of the protein (Fig 
2-23B). The aggregation peak directly after the void volume was very high and 
indicated a large fraction of high molecular mass aggregates in the region between 8-
10 ml. The elution volume of 11.9 ml indicated the same molecular mass as at 4 °C, 
200 kD. When comparing the two SEC profiles at the different temperatures it was 
obvious that the stability of the protein was improved at 4 °C. The effective absences of 
aggregates and a single, symmetric SEC peak show a monodisperse and stable protein 
that did also not show signs of aggregation after several days at 4 °C. This protein has 
thus very promising properties for crystallization. 
A second detergent tested for purification of MaCCC was Fos-cholin 12 since it also 
showed good membrane extraction properties.  The preparation was carried out at 4 °C 
with the optimized parameters for IMAC mentioned above. The SEC elution profile in 
Fos-cholin 12 at 4 °C showed a different chromatogram than observed for DM (Fig 
2-24). The main elution peak at 10.9 ml corresponds to an apparent molecular weight of 
350 kD, 1.5 times higher than observed in DM. A shoulder as result of two overlapping 
peaks eluted at 12.5 ml (apparent molecular weight=160 kD). The high absorption at the 
void volume corresponds to protein aggregation. The reinjection of the main fraction 
around 10.9 ml recovered a single elution peak at the same volume. The observed 
 
Fig 2-24 MaCCC Purification in Fos-cholin 12 
MaCCC was solubilized and further purified in Fos-cholin 12. The SEC with a S200 column revealed a 
main elution at 10.9 ml corresponding to a dimer with a shoulder at 12.5 ml. Major protein quantities 
eluted directly after the void volume (arrow). The retention volume indicated in [ml] is plotted against the 
absorption at 280 nm 
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difference in the elution volumes of the different peaks of Fos-cholin 12 was probably 
due to different oligomeric states. The difference in the main peak retention volume 
between Fos-cholin 12 and DM either corresponded to different oligomeric states or a 
change in the elution properties due to the difference in the detergent micelle. 
The detergent exchange from DM into other detergents was investigated to identify 
other protein detergent complexes for crystallization. After purification in DM aliquots 
of the main peak fraction of MaCCC after SEC were dialyzed overnight into different 
detergents. After 12-18 h dialysis the elution profiles of MaCCC were assayed in a 
column equilibrated in the detergent dialyzed against. In the detergents OM, NM, DDM 
and LDAO, MaCCC was reasonable stable and eluted at SEC at a volume of around 
11.9 ml (213 kD) as single, symmetric peak (Fig 2-25). With decreasing chain-length of 
the hydrophobic tail OM<NM<DDM the chromatogram showed a partial cleavage of 
the C-terminal cytoplasmic (15.6 ml – 34 kD) from the full-length protein. In contrast to 
 
Fig 2-25 MaCCC Detergent Stability Test 
SEC of MaCCC in different detergents. Aliquots of the main SEC peak of MaCCC in the presence of DM 
were dialyzed overnight into different detergents and subjected to SEC using a column equilibrated in the 
new detergent. The chromatograms show single peaks at a similar elution volume in OM, NM, DDM and 
LDAO. The void volume is indicated by an arrow. The retention volume indicated in [ml] is plotted 
against the absorption at 280 nm 
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maltosides and LDAO, the exchange into C12E9 and OG has led to the precipitation of 
the protein during dialysis. 
Since the previous experiments indicated that MaCCC might dissociate into 
monomers I have investigated the stabilization of oligomeric protein by 
supplementation of lipids to the purification buffers. MaCCC-His10 was purified as 
previously described but with addition of E. coli polar lipids at a concentration of 
0.1 mg/ml throughout the purification. After removal of the His10-tag using the 3C 
protease the subsequent SEC with a S200 column showed a dominant elution peak at a 
volume of 10.8 ml (Fig 2-26). This volume was shifted with respect of the elution 
volume in the absence of lipids by 1.1 ml and corresponds to an apparent molecular 
mass of 370 kD. The protein was stable for several days at 4 °C in the SEC buffer 
containing lipids and did not change its elution volume upon reinjection. With the 
improvement of the expression using autoinduction medium, the optimization of the 
IMAC protocol taking advantage of the His10-tag and the addition of lipids during 
purification the overall yield was reproducibly around 200 µg purified protein/liter of 
expression culture. 
 
Fig 2-26 MaCCC-10His SEC in DM+Lipids 
SEC of MaCCC in DM in the presence of lipids. (A) The chromatogram shows a symmetric elution peak 
at 10.8 ml with a little aggregate peak at the void volume (arrow). (B) The fractions 1-8 (bar in A) were 
analyzed by SDS-PAGE and coomassie stain. The pooled and concentrated fractions 5 and 6 are shown in 
lane C. The retention volume indicated in [ml] is plotted against the absorption at 280 nm 
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2.3.3.3.1 The Oligomeric state of MaCCC 
 
The observed difference in retention volumes in SEC in the absence and presence of 
lipids indicate a lipid-dependence of the oligomerization of the protein. This behavior 
was investigated in detail. The knowledge of the structural organization of the isolated 
C-terminal domain of MaCCC (see chapter 2.4.1) guided the mutation of residues in the 
proposed dimer-interface in full-length MaCCC. E505 and Q622 located in proximity in 
the proposed interface of the C-terminal domain were mutated to cysteines to allow a 
covalent crosslinking by disulfide bond formation. The oligomeric behavior was 
followed by SDS-PAGE and multi angle light scattering (MALS). After purification of 
MaCCC E505Q622C under oxidizing conditions (air O2) the protein was applied to 
SDS-PAGE separation under oxidizing conditions (Ox) or to reducing conditions by 
addition of 0.5 mM TCEP (Red) (Fig 2-27). The oxidized mutant migrated around 
250 kD, the molecular weight of a dimer. After reduction of the disulfide bridge the 
mutant showed a similar monomeric migration behavior as wild-type MaCCC (around 
70 kD), which strongly suggests that MaCCC forms dimers. The result, however is only 
qualitative and should be taken with caution, since even a dimeric protein in equilibrium 
with its monomeric would quantitatively crosslink upon prolonged incubation. 
The oligomeric state of MaCCC was also analyzed using SEC-MALS with UV and 
dRI detection (Slotboom, Duurkens et al. 2008). This method uses the scattering 
intensities of particles in solution as function of the scattering angle and concentration. 
The resulting K*c/R (with K…optical constant, c…concentration, R…Raleigh constant) 
for each angle is plotted and extrapolated to determine the molecular weight. The SEC 
 
Fig 2-27 MaCCC Cysteine Crosslink 
MaCCC E505Q622C was purified under oxidizing conditions and subjected to SDS-PAGE. Keeping the 
oxidative environment intact (Ox, left lane) led to a 250 kD migration behavior. Under reducing 
conditions in 0.5 mM TCEP decomposition of the cysteine bridges reconstitute the migration behaviour 
of the wild-type around 70 kD. 
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column separates the protein prior to the MALS measurement according to molecular 
weight to increase the signal quality (polydispersity). The S200 SEC column was 
equilibrated with running buffer containing DM and lipids until RI and scattering signal 
leveled at baseline. The scattering signals were calibrated with BSA. 
200 µg of MaCCC E505Q622C were injected onto the column under oxidizing 
conditions. The chromatogram and the calculated masses are depicted in Fig 2-28. The 
elution volume of MaCCC of 11 ml was close to the low elution volume found in 
previous experiments from MaCCC in the presence of lipids. The corresponding 
molecular mass of the PDC (protein detergent complex) was 312 kD (0.2 % error). The 
 
Fig 2-28 SEC-MALS of Oxidized MaCCC E505Q622C 
The double mutant MaCCC E505Q622C containing cysteine mutations in the proposed dimer interface 
was analyzed using SEC-MALS with RI (refractive index) and UV detection under oxidizing conditions. 
The normalized UV280nm absorption (left axis) and the molar mass (right axis) are plotted against the 
retention volume of an S200 column. The peak elution is 11.2 ml with the indicated mass of the PDC 
(protein detergent complex) (dark blue), protein core (light blue) and the detergent micelle around the 
protein (green). 
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weight of the protein core was calculated to be 185 kD (0.2 %) with a polydispersity 
Mw/Mn=1.000 (0.3 %) and the limits of 10.8 to 11.2 ml. Since the molar mass of a 
MaCCC monomer is 83 kD this peak thus most probably corresponds to the oligomeric 
state of a dimer. 
When 200 µg of reduced MaCCC E505Q622C was subjected to the same analysis a 
different mass distribution was observed. Partial reduction of the cysteine bridges in the 
dimer interface led to formation of a double peak with retention volumes of 11.2 and 
12.7 ml (Fig 2-29). The peak at 11.2 ml corresponds to the dimer observed before 
(PDC=300 kD (0.3%) with a protein core of 165 kD (0.3%), elution volume limits 
 
Fig 2-29 MALS of Reduced MaCCC E505Q622C 
MaCCC with introduced cysteine mutations in the proposed dimer interface E505Q622C was analyzed 
using SEC-MALS with RI (refractive index) and UV detection after incubation of the protein with 
0.5 mM TCEP for reduction of the cysteine bridges. The normalized UV280nm absorption (left axis) and 
the molar mass (right axis) are plotted against the retention volume of an S200 column. The elution 
volume of the first peak is at 11.2 ml. The masses of the PDC (dark blue), protein core (light blue) and the 
detergent micelle around the protein (green) are indicated. The second peak belonging to the reduced 
protein has a retention volume of 12.7 ml. The molar masses of the PDC (red), protein core (pink) and the 
detergent micelle (brown) are indicated. 
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between 10.9 and 11.6 ml and Mw/Mn= 1.001(0.5 %)). The second peak at 12.7 ml, 
however, belongs to a different oligomeric state. The mass of the calculated PDC was 
188 kD (0.7 %), with a protein content of 99 kD (0.8 %), elution volume between 12.5 
to 13 ml (Mw/Mn=1.000(1 %)). 
The MALS experiment strongly suggests that the lower elution volume seen in SEC 
corresponds to a dimer of the protein, while the peak at the higher volume is due to 
MaCCC monomer. The formation of disulfide bridges confirms the proximity of the 
residues in the dimeric protein. These mutations can be used to stabilize the oligomeric 
state of MaCCC. Additionally, to fix MaCCC in a defined conformation on the transport 
cycle might prove to be essential for a future crystallization of the protein. 
2.3.3.4 Summary 
In the course of this project I have screened the overexpression and biochemical 
characterization of 17 prokaryotic homologues of cation chloride cotransporters. The 
broad screening efforts included the use of two different expression hosts, E. coli and L. 
lactis, and the fusion of N-terminal or C-terminal His-tags and C-terminal GFP fusions. 
Using E. coli and the strong T7 promoter system only one homologue, MaCCC, could 
be overexpressed in a DM/DDM soluble state (with an overall yield of 200µg of protein 
per liter of culture). The protein was purified and subjected to crystallization. Whereas 
other homologues, like SynCCC and SfCCC, were also overexpressed at suitable levels 
, they were only extractable with Fos-cholins and were prone to aggregation. Changing 
to the tuneable pBAD system facilitated the expression of other candidates such as 
SynCCC, PiCCC, PmaCCC and SrCCC in a putatively folded state (as judged by in-gel 
fluorescence of GFP fusion proteins). After extraction with DDM these proteins could 
be purified by IMAC and analyzed with SEC. During this procedure only MaCCC 
protein was identified as stable and monodisperse protein. Other well expressing 
homologues like SrCCC, PiCCC and PmaCCC showed strong aggregation behavior 
after solubilization. While SynCCC was purified as stable peak after gel filtration its 
yield was very low (50µg of protein per liter of culture). The expression of proteins 
carrying a N-terminal His-tag was unsuccessful for most constructs. 
L. lactis offered the choice to express CCCs in a Gram-positive expression host. 
Expression under the control of the PNIS promoter could be detected for most of the 
investigated homologues as C-terminal GFP and His-tag fusion proteins. With N-
terminal His-tag fusion only SrCCC showed expression. PiCCC, SrCCC, and PmaCCC 
were purified in DDM and showed a symmetric elution peak on SEC column. The total 
yields of expressed proteins were so little that L. lactis was not investigated further and 
the priority was given to homologues expressing in E. coli. 
2.3.4 Crystallization 
All purified constructs were broadly screened for crystallization in a broad protein 
concentration range from 3-15 mg/ml. In the first crystallization trials with MaCCC 
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purified with His6-tag only crystals from ubiquinol oxidase that co-purified as impurity 
were observed. With the improved protein purity and the supplement of lipids the 
crystallization was attempted in different detergents but still did not provide any 
promising leads. 
Beside the wild-type protein, also the crosslinked MaCCC mutant with an introduced 
disulfide bond in the domain interface, which potentially stabilizes the protein, was 
subjected to crystallization screening but did not yet provide any promising results 
either. 
2.3.5 Materials and Methods 
 
Preparation of Genomic DNA (gDNA). The cell pellet of the prokaryotic organism 
was resuspended in 0.25 M Tris-HCl pH 8.0, 25 % (w/v) sucrose, 10 mg/ml lysozyme 
and incubated for 1 h at 37 °C. After addition of 1 % (w/v) SDS and 200 µg/ml 
proteinase K the lysis solution was again incubated for 1 h at 65 °C. The proteins were 
extracted once 1:1 with phenyl:chloroform:isoamyl acohol (25:24:1) pH 8.0 and the 
aqueous solution was washed at least three times 1:1 using chloroform:isoamyl alcohol 
(24:1). DNA was precipitatd by mixing the aqueous phase 1:1 with isopropanol and 5:1 
with 7.5 M ammonium acetate and incubation for 30 min at -20 °C. The DNA was 
pelleted by centrifugation (15 min, 4 °C, 16000 g) and washed once with ice cold EtOH. 
The pellet was resupended in 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA pH 8.0 and 
kepped at 4 °C for immediate use and at -20 °C for storing. 
 
PCR. For amplification of the gene different polymerases were used to obtain a full 
set of genes. The PCR was mixed according to the manual for Pfu polymerase 
(Fermentas), Vent polymerase (NEB) and thermoprime Mastermix (ABgene) 
supplemented with 50 µg of genomic DNA, 0.4 µM of forward and reverse primer and 
4 % DMSO. The reaction was performed after hot start with 35 cycles of a temperature 
protocol that includes melting at 95 °C for 60 s, annealing for 45 s at 53 °C elongation 
according to the protocol of the polymerase. The PCR was finished by a final elongation 
step for 6 min at the optimal polymerase temperature. The PCR reaction mix was 
subsequent separated by agarose gel electrophoresis, and the expected DNA bands 
excised and purified with the NucleoSpin purification kit (Roche). 
 
Ligation. For ligation the linearized plasmids was mixed with the digested insert at a 
molar ratio of 1:5 supplemented with reaction buffer and 400 U of T4 DNA ligase 
(NEB), adjusted to a final volume of 20 µl and incubated for 3 h at 16 °C. 
 
Transformation of E. coli. 50 µl of chemically competent cells were thawed on ice 
and incubated for 10 min with the DNA. Heat shock was performed at 42 °C for 45 sec 
with following chilling on ice for another 10 min. After addition of 200 µl LB medium 
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the cells were grown for 1 h at 37 °C and plated on LB agar plates with incubation at 
37 °C overnight until growth of colonies. 
 
Expression Test of Prokaryotic Homologues. After transformation at least three 
colonies were picked for each construct and grown as precultures overnight at 37 °C in 
LB-medium. The preculture was diluted 100 times with the expression medium (mostly 
TB medium). After growing to an OD600nm=0.5 at 37 °C the cultures were induced and 
grown for 3 h or they were cooled to 25 °C and induced with following incubation 
overnight. For analysis aliquots of roughly 1 mg of total protein (1ml of OD600nm=3.3) 
were taken and the cell pellet prepared by centrifugation. 
 
In-Gel GFP Fluorescence Detection from (Geertsma, Groeneveld et al. 2008). 
Whole-cell expression samples equivalent to ~1 mg of total protein were resuspended in 
400 μl ice-cold lysis buffer (50 mM KPi (pH 7.2), 1 mM MgSO4, 10 % (w/v) glycerol, 
1 mM PMSF and 20 µg/ml DNase). After addition of glass beads (300 mg, 0.1 mm 
diameter) the samples were broken in a FastPrep device (Bio101) for two times 20 s at 
force 6 with 5 min cooling on ice between the runs. 25 μg of total protein samples were 
analyzed by SDS/PAGE, and in-gel GFP fluorescence was visualized with an LAS-
3000 imaging system (Fujifilm) and analyzed with the AIDA software (Raytest). 
Subsequently, gels were submitted to semidry electroblotting and immunodetection 
with. Chemiluminescence was detected using Fujifilm LAS-3000 imaging system. 
 
Differential Sedimentation of Folded and Aggregated Proteins from (Geertsma, 
Groeneveld et al. 2008). Whole-cell expression samples were prepared as described for 
in-gel fluorescence. After bead beating, aliquots of 100 μl were solubilized for 60 min at 
4 °C in the presence of 1 % (wt/vol) DDM with continous mixing. After saving a small 
aliquot (20 μl, 45 μg) to represent the sample before ultracentrifugation, the remaining 
sample was centrifuged at 355,000 × g for 15 min at 4 °C in a TLA 100.1 rotor. Both 
aliquots with 25 µg total protein were separeted by SDS-PAGE and analyzed by anti 
His-tag immunodetection. 
 
Analysis of Overexpression with His-tag Detection. Whole-cell expression 
samples corresponding to 600 µg total protein were lysed in 100 µl of 5 M urea and 
50 µg were separated by SDS-PAGE and analyzed by anti His-tag Western blot using a 
primary HRP coupled antibody against a His6-tag (Roche) 
 
Expression of Full-Length CCCs. Full-length MaCCC, transformed in E. coli BL21 
(DE3) cells were grown as preculture overnight in LB medium. Cultivation started with 
1 % (v/v) dilution into autoinduction media supplemented with 50 μg/ml kanamycin at 
30 °C and incubation overnight. An onernight preculture of the additional CCCs  
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Isolation of Membrane Vesicles. Cells were harvested and lysed with an Emulsiflex 
C3 high pressure homogenizer (Avestin) in 50 mM Tris-HCl (pH 8.0), 150 mM NaCl 
(buffer A) with addition of 1 mg/ml lysozyme, 20 µg/ml DNase, 1 µg/ml leupeptin, 
1 µg/ml pepstatin and 1 mM phenylmethyl sulphonyl fluoride (PMSF) with two 
passages with at least 700 bar. The lysate was cleared by low-spin centrifugation 
(30 min, 10000 x g) and the membranes pelleted with high-spin centrifugation (1 h, 
100000 x g) and flash frozen in liquid N2 and stored at -80 °C. 
 
Purification of Prokaryotic CCC with His10-Tag. The membranes were thawed on 
ice and resuspended in buffer A (50 mM Tris-HCl pH 8.0, 150 mm NaCl) + 10 % (v/v) 
glycerol  at a ratio of 10 ml buffer A per 1 g of membranes. Solubilization was started 
with the addition of 2 % [w/v] DM (or other detergent) and incubation for 2 h with 
subsequent centrifugation (30 min, 100000 x g). The supernatant was incubated in batch 
with equilibrated Ni-NTA (Quiagen) after addition of 15 mM imidazole for 30 min. The 
resin was washed with buffer A + 50 mM imidazole on column until baseline and the 
protein eluted with buffer A + 300 mM imidazole. The elution fraction was immediately 
supplemented with 5 mM EDTA to complex leaking Ni
2+
. For cutting of the His-tag 
HRV 3C protease (GE Healthcare) was added at a molar ration 1 mol protease for 5 mol 
target protein. After incubation for 2 h the protein solution was concentrated to 500 µl 
with an Amicon Ultra Centrifugal filter device (MWCO=100 kD, Milipore). The 
concentrated protein was injected onto a gel filtration column (Superdex 200 10/300 
GL, Äkta Prime system, GE Healthcare) equilibrated with running buffer (10 mM Tris-
HCl pH8.0, 150 mM NaCl, 5 mM DM). Elution was recorded with absorption at 
280 nm. All steps were carried out at 4 °C. 
 
Detergent Exchange. After SEC the new detergent was added to the protein at a 
concentration of 3xCMC and dialyzed against 500 x sample volume dialysis buffer with 
3xCMC of the new detergent overnight at 4 °C. For testing the stability in the new 
detergent an additional SEC was done using the new detergent. 
 
Crystallization. After SEC the protein was concentrated with an Amicon Ultra 
Centrifugal filter device (MWCO=100 kD, Milipore) to 5-12mg/ml. In a standard sitting 
drop experiment 100nl of protein solution were mixed with 100nl precipitant solution 
by a robotic system at 20 °C and incubated against the precipitant solution at 4 °C and 
20 °C 
 
Mutation and Disulfide Bridge Formation. Mutations were inserted with the 
QuikChange method (Stratagene) and confirmed by sequencing. Mutant proteins were 
purified following the same protocol as for WT. For crosslinking studies all constructs 
had the His-tag removed. The respective disulfide bridges formed spontaneously upon 
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exposure to air or after addition of 1 mM Na2S4O6 and were reduced by addition of 
5 mM β-mercaptoethanol or 5 mM TCEP. The proteins were analyzed by SDS-PAGE. 
 
Multi-Angle Light Scattering. MALS was performed with an experimental set up 
consisting of an Äkta explorer with a S200 column (GE Healthcare) and UV-detector 
(A900, GE Healthcare) followed by a differential refractometer (OPTILAB rEX, Wyatt 
technology) and a miniDAWN MALS detector (Wyatt technology). The columns and 
detectors were equilibrated with running buffer (10 mM phosphate buffer pH 7.5, 
150 mM NaCl, 5 mM DDM,) until baseline and a calibration run was performed with 
100 µg BSA to align the signals. 100 µg of purified protein was injected onto the 
column and the UV280nm, the refractive index (RI) and the scattering signals were 
recorded. The data was analyzed using Astra V software (Wyatt technology). Since the 
protein accounts with known amount to the UV absorption and RI and the detergent 
DDM only to the RI the protein contribution to the protein detergent complex MALS 
signal can be calculated. The modifier dn/dc for the detergent was set to 0.47 based on 
oral communications with T. Huber (Dissertation Thomas Michael Huber 2007, 
University of Zurich). 
2.4 C-terminal Domain of CCCs 
Soluble domains of transport proteins frequently play an important role in the 
regulation of transport in response to phosphorylation or ligand binding. They can serve 
as interaction platform with other proteins. These domains can often be expressed as 
soluble proteins, which makes them easier amendable to crystallization and structure 
determination. Additionally the isolated domains facilitate biochemical investigations 
such as binding assays to identify regulating ligands. These experiments are easier on 
soluble domains compared to labile, detergent solubilized membrane proteins. 
Moreover, the structure solution of these domains provides initial insight into the 
organization of the protein which is valuable for the purification, crystallization and 
structure solution of the full-length transporters. In cation chloride cotransporters the C-
terminal domain accounts for 30-40% of the protein and is predicted to form a folded 
structure. While for eukaryotic CCCs the domain is a target for phosphorylation, so far 
no ligand was found to bind to specific sites in the proteins. 
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Different constructs of the isolated domain of prokaryotic CCCs were designed on 
the basis of hydrophobicity predictions that indicate the boundary between the 
membrane part and the start of the domain. After the successful structure determination 
of the domain of MaCCC the expression constructs of the cytoplasmic domains of other 
homologues were structure-based. The expression of the C-terminal domains from 
different prokaryotic homologues proved to be very difficult, since all C-terminal 
domains (Cdom) besides the MaCCC Cdom were expressed in inclusion bodies. The 
variation of temperature, media, inducer concentration and construct length had no 
influence on this behavior. Also the fusion of a solubility tag like MBP lacking the 
export signal did not change the excessive aggregation of the protein in the cell. 
Multiple constructs were designed based on stepwise truncations of 5 amino acids. The 
C-terminal domains of different homologues (Tab 2-1) were expressed in E. coli BL21 
(DE3) cells in LB medium. Expression was induced at OD600nm=0.5 with 0.5 mM IPTG 
for 3 h at 37 °C or overnight at 20 °C. The cells were lysed and the soluble fraction 
separated by centrifugation (Fig 2-30). Apart from the MaCCC C-terminus, all 
investigated constructs sedimented through centrifugation, indicating that they were 
expressed in inclusion bodies. Only the C-terminal domain of MaCCC allowed soluble 
expression and was used for functional investigations and structure determination. 
2.4.1 Methanosarcina acetivorans C-terminal Domain 
The C-terminal domain of MaCCC is 32kD large and constitutes nearly 40% of the 
full-length protein. The first construct used for expression trials of the C-terminal 
domain from MaCCC was designed to start approximately after the predicted last 
transmembrane helix at residue H450 (Fig 2-31). 
 
Fig 2-30 Expression Test of Prokaryotic C-Terminal Domains 
The C-terminal domains of the depicted homologues were expressed in LB medium using E. coli BL21 
(DE3) cells. After induction at OD600nm=0.5 the cells were incubated for 3 h at 37 °C or overnight at 
20 °C. The samples were centrifuged following cell lysis and analyzed by Western blot. The signal 
corresponding to the domains is indicated by an arrow. P... pellet, SP... supernatant 
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The domain was initially expressed with a C-terminal His6-tag fusion without 
protease site for 3 h at 37 °C using E. coli BL21 (DE3) cells and 0.5 mM IPTG. These 
conditions gave sufficient protein for initial purification trials. The IMAC purification 
started with binding to a Ni-NTA column and washing with 15 mM imidazole. The 
protein was completely eluted from the resin with 300 mM imidazole. SEC revealed a 
predominant peak at 12.3 ml corresponding to an apparent molecular weight of 175 kD. 
SDS-PAGE analysis showed that the protein is partly degraded (Fig 2-31A) and 
allowed the identification of four degradation products. Since anti His-tag Western blot 
analysis showed a signal for all 4 protein fragments, the degradation occurred at the N-
terminus which left the C-terminal His6-tag attached. MALDI-MS analysis identified 
three specific breaking points at the N-terminal tail, L458, E475 and S483 (Fig 2-31B, 
dashed flashes). The low yield of only 50 µg purified protein per liter of expression 
culture also indicated a suboptimal expression construct. Partial proteolysis in the linker 
region separating the membrane part and the C-terminal domain was already observed 
during purification of the full-length transporter. In this case the cleavage was identified 
by MALDI-MS at residue V473 (Fig 2-31B, solid flash). The new construct was thus 
designed combining the information from the first domain purification trials and the 
experience from the purification of full length MaCCC. With a construct starting at 
residue V473 a clean, monodisperse, stable protein species could be purified with a 
 
Fig 2-31 MaCCC C-Terminal Domain Construct Design 
The truncation of MaCCC to have the C-terminal expression construct was initially based on 
hydrophobicity analysis. The last transmembrane segment is assigned [TM12, gray] as well as the 
cytosolic part belonging to the C-terminal domain [green]. The first construct started at H450. This 
construct showed several degradation products on the protein level analysed by MS at its N-terminal 
region (dashed flashes). Combined with the experience of purification of full length MaCCC which also 
fell apart (flash), a new construct was designed starting at residue V473 which was highly expressed and 
stable. 
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yield of 3 mg purified protein per liter of expression culture (Fig 2-32). The elution 
volume corresponded to an apparent molecular weight of 170 kD which would be in the 
appropriate range of either a pentamer (5*33 kD=165 kD) or a hexamer 
(6*33 kD=198 kD).  
Based on the truncated domain construct a second construct was designed that 
includes a C-terminal 3C protease site to remove the His6-tag. Both protein constructs 
were used for the characterization by X-ray crystallography and analytical 
ultracentrifugation (AUC). 
I have used AUC to get quantitative insight into the oligomeric organization of the 
MaCCC Cdom. AUC measures the influence of a centrifugal field on the concentration 
distribution of the traced compound. The experiment can be set up as sedimentation-
velocity or sedimentation-equilibrium experiment. Sedimentation-velocity AUC allows 
the determination of the sedimentation coefficient S and approximate estimation of the 
molecular weight (Schuck 2000). Sedimentation-equilibrium AUC in contrast allows 
the measurement of the diffusion coefficient, which can be used to calculate the exact 
molecular mass, with the determined S of the velocity experiment. The measured S is 
still dependent on the buffer composition, temperature and the protein concentration. 
The calculation of S in water at 20 °C at infinite dilution abolishes the influence of 
measurement parameters and creates a condition independent S20, H2O. The sedimentaion 
coefficient allows only indirect conclusion to the molecular weight.  
All measurements described here were carried out as sedimentation-velocity 
experiments at 15 µM protein concentration, pH=7.0 and 4 °C (Fig 2-33). The MaCCC 
Cdom lacking the protease site and still containing the His6-tag sediments at a S=9.0 
(blue curve). In contrast, the removal of the His6-tag, or the increase of the pH to 9.5 led 
 
Fig 2-32 MaCCC Cdom Purification 
(A) After redesign of the expression construct, MaCCC Cdom was purified and eluted as single 
monodispers peak on SEC at 12.4 ml. Nearly no aggregates were present (arrow). The four main peak 
fraction (1-4) were further analyzed on SDS-PAGE. The retention volume indicated in [ml] is plotted 
against the absorption at 280 nm. (B) Coomassie stain of the main peak fractions (1,2,3,4) and the 
concentrate (C) of fraction 2 and 3. 
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to a shift to a smaller sedimentation coefficient at S=2.4 (red curve). Finally, the 
mutation of an essential interface residue responsible for major interactions in the 
interaction interface shifted S to 1.7 (for discussion see Publication 2.4.1.2). By 
converting the sedimentation coefficient to its S20, H2O value and by taking the diffusion 
coefficient and molecular shape of the protein into consideration, these sedimentation 
behaviors correspond to the molecular masses of 9.0 S=190 kD, 2.7 S=51 kD and 
1.7 S=30 kD. Since the mass of a subunit of MaCCC Cdom is 33 kD, the peaks 
correspond to a hexamer, dimer and monomer, respectively. 
 
For structural analysis MaCCC Cdom His6 was subjected to crystallization screening. 
In a sitting drop experiment crystal were observed at a condition containing 100 mM 
MES (pH 6.5) and 1.1 M MgSO4. These crystals belong to the trigonal space group 
P3221 and diffracted to a resolution of 1.9 Å and allowed the collection of a complete 
data set. 
 
Fig 2-33 Analytical Ultracentrifugation of MaCCC Cdom 
The distribution of the sedimentation coefficient (c(S)) of an AUC experiment with different constructs of 
MaCCC Cdom is plotted against the sedimentation coefficient. MaCCC Cdom His6-tag (blue, with His) 
sediments at 9 S. Introduction of a 3C protease site and removal of the His-tag resulted in a shift to S=2.7 
(red, w/o His). The mutation of an essential interface residue R154A resulted in S=1.7 (green, R154A). 
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To determine the phases of the structure factors the protein was expressed in minimal 
medium supplemented with all amino acid besides methionine. Seleno methionine (Se-
Met) was added to be incorporated at methionine positions and the incorporation was 
confirmed by mass spectrometry (Fig 2-34). Since MaCCC Cdom has 10 methionines in 
its sequence, the replacement by Se-Met results in a mass difference of 470 Da in case 
of complete derivatization, which was observed in the MALDI-TOF-MS (Se-Met 
protein 33705 Da, wild-type protein 33235 Da, Δ=470 Da). 
Crystals of Se-Met protein grew in the same condition as the native protein. A 
 
Fig 2-34 MaCCC Cdom Se-Methionine Derivatization 
ESI-TOF-MS of (A) native MaCCC Cdom and (B) Se-Methionine derivatized MaCCC Cdom. The 
relative intensity (highest peak=100%) is plotted against mass. The mass of the peaks with the highest 
intensity is labeled. 
 
Fig 2-35 MaCCC Cdom SAD Data Collection Statistics 
After collection of Se methionine substituted crystals the collection parameters were plotted against 
resolution. Intensity over standard deviation (I/σ, blue, left axis), anomalous difference over standard 
deviation (│F+-F-│/σ, red, right axis). 
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dataset of these crystals was collected at the selenium κ absorption edge for maximizing 
the anomalous differences. The data collection was performed at high redundancy to 
improve the statistics of the anomalous signal. After scaling and merging of the data 
(where Friedel pairs were kept separated) the magnitude of the anomalous contributions 
were analyzed by plotting the intensity (I/σ) and the anomalous difference (│F+-F-│/σ) 
against resolution (Fig 2-35). At a resolution of 2.5 Å the anomalous difference was still 
above background (1.2) which was chosen as cut-off for phase determination. 
The structure was determined by single wavelength anomalous dispersion (SAD). 
Since the asymmetric unit contains a single subunit, as indicated by calculation of the 
Matthews coefficient, 9 selenium sites were expected to contribute to the anomalous 
scattering assuming the first Se-Met to be unordered. Using the programs SHELXC and 
SHELXD 7 selenium sites were located and refined (Fig 2-36). 
Initial SAD phases were improved by 20 cycles of density modification and solvent 
flipping with SHELXE, which allowed the determination of the correct hand of the 
selenium coordinates (Fig 2-38). 
 
Fig 2-36 Heavy Atom site Occupancy After Heavy Atom Search in SHELXD 
The heavy atom site occupancy is plotted against the Se sites. 8 sites could be determined including 7 
with high occupancy (1-7). 
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The improved electron density allowed model building and initial refinement in 
 
Fig 2-38 Density Modification in SHELXE 
Progress of density modification. The contrast is defined as the variance of V (variance of the density on 
spherical surface with radius 2.42 Å) averaged over all pixels of the electron density. The pseudo-free 
correlation coefficient (Pseudo-free CC) is calculated at the end by leaving out 10 % of reflection at 
random and doing one round of density modification with application of the improved phases. If the 
density modification converges and the difference between both solutions is high, the right enamtiomorph 
can be distinguished. The original solution (red) strongly improved the contrast and converged. In 
combination with the high Pseudo-free CC these were good indicators for the right solution. 
 
Fig 2-37 Electron Density of MaCCC C-Terminal Domain 
(A) Initial experimental electron density and (B) 2Fo-Fc electron density after completed refinement. The 
density was calculated to 2.5 Å and 1.9 Å for A and B respectively and contoured at 1.5 σ. The electron 
density is superimposed on the refined structure of MaCCC Cdom (residue 28-46 with α helix residues, 
light blue and loop residues, light red). The experimental map was calculated from native amplitudes and 
solvent flattened SAD phases.  
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Phenix. The final refinement was carried out against the native data set at 1.9 Å by 
simulated annealing with Phenix. The improvement of the electron density during 
refinement is illustrated in Fig 2-37. Compared to the initial density calculated from 
experimental phases the final model phases improved considerable. While the initial 
electron density clearly showed the secondary structure elements and side chain 
conformations of bulky residues like tyrosines, the final density additional 
unambiguously defines the atomic positions of the main and side-chain atoms. 
 
2.4.1.1 Additional Crystal forms 
Upon the broad crystallization screening of the MaCCC C-terminal domain different  
crystal forms were identified that show variations in the crystal packing and thus 
provide insight into the oligomeric organizations of the domains. The first crystal form 
observed that also allowed the high resolution structure determination to 1.9 Å was of 
construct with - w/o His tag crystal form resolution [Å] 
domain-His6 with P3221 1.9 
domain-3C-His6 w/o C222 3.0 
domain-3C-His6 w/o I41 2.85 
Tab 2-6 Crystal Forms of MaCCC C-Terminal Domain 
 
Fig 2-39 Crystal Contact in Crystal Form P3221 
Two neighbouring domains in crystal form P3221 are depicted in blue and green. The residues of the 
interacting helices are shown as sticks. The C-terminus of the blue domain (red) forms a short α-helix. 
Additional residues with α-helical propensities elongate this helix that can interfere with the crystal 
contact. 
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space group P3221. This construct had the His6-tag attached directly after the protein, 
which was not removed upon crystallization. In an attempt to observe different crystal 
packing, to distinguish between native interactions and crystal contacts and thus to 
define the native dimer interface the construct was varied. A protease site between the 
protein and the His6-tag was introduced, which allowed the crystallization and structure 
determination of the MaCCC C-terminal domain in the space groups C222 and I41 by 
molecular replacement. 
Although the crystal forms belong to different space groups important features of the 
crystal contacts observes in the P3221 space group are also observed in other crystal 
forms. 
In Tab 2-6 it is illustrated that the length of the C-terminus and the presence of the 
His-tag had a large influence on the crystal symmetry and resolution. The analysis of 
the packing requires a thorough inspection of the crystal contacts. One contact is 
mediated by few residues near the C-terminus that protrudes from the surface (Fig 
2-39). For the high resolution structure of the protein all residues were resolved 
including the first histidine of the His6-tag. The last five histidines of the tag were 
disordered and thus not resolved in the structure. In this case six additional amino acids, 
histidines, were added to the C-terminus. For the constructs harboring a protease site 14 
amino acids are added to C-terminus that reduces to six additional residues upon 
cleavage of the tag. These six residues (LEVLFQ) are remaining on the terminus (Fig 
2-14) and they have large α-helical propensities and could thus interfere with a proper 
packing of the crystals. 
The introduction of additional residues at the termini of the protein has to be 
considerably investigated since these might influence crystallization. The protease sites 
most commonly used for crystallization are suited for N-terminal cleavage because in 
this case they only add 2-3 residues to the protein. If they are used C-terminally they 
Protease Cleavage Site 
C-Terminal 
Overhang [bp] 
TEV E-Xaa-Xaa-Y-Xaa-Q-*(G/S) 6 
HRV 3C protease L-E-V-L-F-Q-*G-P 6 
Factor Xa I-(E/D)-G-R* 4 
Thrombin L-V-P-R-*G-S 4 
Enterokinase D-D-D-D-K* 5 
Tab 2-7 Protease Sites and Their Overhangs 
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add up to six residues (Tab 2-7). Only Factor Xa and thrombin cleavage sites produce 
comparably short overhang. The disadvantage of these proteases however, is the low 
catalytic activity at 4 °C where purifications of moderately stable proteins have to be 
carried out. 
The statistics for data collection and structure determination and a detailed analysis 
of the crystal packing is described in the following chapter as part of a published 
manuscript. 
2.4.1.2 Publication 
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2.4.1.2.1 Supplementary data 
 
Fig S-1 Unstructured regions in human NKCC2. 
The sequence of human NKCC2 (accession number SLC12A1) was analyzed with respect to the 
probability to fold into a defined conformation. P(d) was calculated with the program DRIPPRED 
(MacCallum 2004) and describes the propensity for disorder. Residues with values above P(d) = 0.5 are 
likely to be unstructured. Different regions are indicated above and shown in unique colors 
(transmembrane regions in grey, insertions with respect to MaCCC in orange and the two halves of the 
cytoplasmic domain in red and green respectively). Insertions at the N-terminus and in loop regions show 
a large propensity for being unstructured. 
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Fig S-2 Sequence conservation in the C-terminal domain 
Multiple sequence alignment of the C-terminus of different prokaryotic CCC transporters and human 
NKCC2. Secondary structure and numbering of the MaCCC domain are shown above. Regions of high 
homology are colored red. Amino-acid sequences are: MaCCC; Methanosarcina acetivorans C2A 
(MA4506), CyaCCC; Cyanothece sp. ATCC 51142, (cce_0839), CwCCC; Crocosphaera watsonii WH 
8501 (EAM51764), LynCCC; Lyngbya sp. PCC 8106 (EAM34907), SynCCC; Synechococcus sp. PCC 
7002 (SYNPCC7002_A1963), TeCCC; Trichodesmium erythraeum IMS101 (Tery_1903), SrCCC; 
Salinibacter ruber DSM 13855 (SRU_2259), PaCCC; Candidatus Protochlamydia amoebophila UWE25 
(GenBank pc0822), SfCCC; Syntrophobacter fumaroxidans MPOB (Sfum_3620), PiCCC, Psychromonas 
ingrahamii 37 (Ping_1733), hNKCC2; homo sapiens (SLC12A1). The Alignment was made with 
ClustalW (Thompson, Higgins et al. 1994). 
 
 
 
 
Fig S-3 Experimental electron density 
Stereo view of electron density (calculated at 2.5 Å resolution and contoured at 1 σ, blue) shown 
superimposed on the refined structure of the MaCCC domain. The map was calculated from native 
amplitudes and solvent flattened SAD phases. Anomalous difference electron density of Se atoms 
(calculated at 3 Å resolution and contoured at 5 σ) is shown in magenta. 
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Fig S-4 Structural homology to USP domain proteins 
(A) Stereo view of a Cα-trace of the MaCCC domain subunit. The two halves of the protein are colored in 
red and blue respectively. The N- and C-terminus is indicated. (B) Cα-trace of an interacting pair of USP 
domains (PDB code 2GM3). The two chains are colored in red and blue respectively, N- and C-termini 
are labeled. (C) Superposition of the Ca traces of the N-terminal sub-domain of the MaCCC C-terminus 
(green) and a single USP domain (red). 
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Fig S-5 Analytical ultracentrifugation of the MaCCC domain 
Distribution of the sedimentation coefficient (c[s]) as calculated from sedimentation velocity experiments. 
The graph shows the distribution for the WT MaCCC domain (
____
) and the domain mutant R627A (- - - -) 
with cleaved-off His-tag, and WT still containing the His-tag (-
 . 
- 
.
 - 
.
 -). The oligomeric states are 
indicated. 
 
Fig S-6 MaCCC domain 'head to tail' dimer 
(A) Stereo view of the MaCCC domain dimer. The view is along the two-fold axis from the extracellular 
side. The two chains are colored in green and orange respectively, ordered water molecules are shown as 
red spheres. (B) View of the dimer in two orientations. The solvent accessible surface (calculated with 
MSMS (Sanner, Olson et al. 1996)) is shown superimposed on a ribbon representation of the protein 
chain. The relationship between the orientations is indicated 
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Fig S-7 Crystal packing 
Two-fold relationships of tightly interacting pairs of MaCCC domains in different crystal forms. The 
interaction interfaces are highlighted ('head to tail' interaction in blue, 'head to head' interaction in 
red).The right panels show a magnified section of the packing. The unit cells are drawn in red. (A) P3221 
crystal form. A pair of proteins forming a 'head to tail dimer' related by crystallographic symmetry is 
shown in blue. (B) C222 crystal form. The asymmetric unit containing a pair of MaCCC domains related 
in the 'head to tail' dimer is shown in blue. The interface in a 'head to head' dimer formed by 
crystallographic symmetry is indicated in red. (C) I41 crystal form. The asymmetric unit consisting of 
four copies of the protein is shown in blue. Two fold relationships within the asymmetric unit for 'head to 
tail' and 'head to head' dimers are indicated in blue and red respectively. 
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Fig S-8 Structure of the 'head to head' dimer 
(A) Stereo view of a ribbon representation of a 'head to head' dimer. The subunits are colored in green and 
orange respectively, N- and C-termini are labeled. The view is along the two-fold axis. (B) Crosslinking 
attempts of adjacent residues in the „head to head‟ dimer interface. Coomassie stained SDS-PAGE of the 
purified MaCCC domain mutants L538C and I559C under oxidizing (ox) and reducing (red) conditions. 
The molecular weight of protein standards and the position of the monomeric protein are indicated. A 
view of the dimer interface perpendicular to the two-fold axis shows the relationship of mutated amino 
acids. Residues belonging to the second subunit are marked (*), the two-fold axis is indicated. (C) 
Distribution of the sedimentation coefficient (c[s]) as calculated from sedimentation velocity experiments. 
The graph shows the distribution for the WT MaCCC domain (
……
) and the double mutant L538A/I559A 
with cleaved-off His-tag. Both proteins sediment as dimers. 
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2.4.2 Materials and Methods 
 
Protein Preparation. The gene encoding the cytoplasmic domain cation-chloride 
cotransporter from Methanosarcina acetivorans (MaCCC, accession number MA4506) 
encompassing residues 474-758 was cloned into a pET28-b+ vector (Novagen) to 
generate constructs of the proteins followed by a C-terminal Herpes simplex (HRV) 3C 
protease site (GE Healthcare) and a His6-tag. A second construct of the MaCCC domain 
was similar but lacked the 3C protease site. For expression of the MaCCC domain E. 
coli BL21 (DE3) cells transformed with the expression construct were grown at 37 °C 
in LB medium containing 50 μg/ml kanamycin to an OD600nm of 0.6. Expression was 
induced by addition of 0.5 mM isopropyl-D-thiogalactopyranoside (IPTG) at 37 ºC for 
three hours. Cells were harvested and lysed with an Emulsiflex high pressure 
homogenizer (Avestin) in 50 mM Tris-HCl (pH 8), 150 mM NaCl (buffer A) with 
addition of 1 mg/ml lysozyme, 20 µg/ml DNase, 1 µg/ml leupeptin, 1 µg/ml pepstatin 
and 1 mM phenylmethyl sulphonyl fluoride (PMSF). The lysate was cleared by 
centrifugation and the protein was purified by affinity-chromatography on a Ni-NTA 
column (Quiagen). For constructs containing the 3C protease cleavage site, the protein 
was digested with HRV 3C protease (GE Healthcare) to remove the His6-tag. After 
concentrating, the protein was subjected to gel-filtration on a Superdex 200 column (GE 
Healthcare). For preparation of seleno-methionine labeled protein, the bacterial culture 
was grown in minimal medium containing 50 mg/l seleno-methionine.  
 
Mutation and Disulfide Bridge Formation. Mutations were inserted with the 
QuikChange method (Stratagene) and confirmed by sequencing. Mutant proteins were 
purified following the same protocol as for WT. For crosslinking studies all constructs 
had the His6-tag removed. The respective disulfide bridges formed spontaneously upon 
exposure to air or after addition of 1mM Na2S4O6 and were reduced by addition of β-
mercaptoethanol. The proteins were analyzed by SDS-PAGE. 
 
Analytical Ultracentrifugation. Sedimentation velocity experiments were 
performed with a Beckman model XL-I analytical ultracentrifuge with a 50-Ti rotor at 
4°C. Double-sector centerpieces were filled with 400 μl of protein samples and 420 μl 
of buffer A. Data were acquired at 280 nm in continuous-scan mode in 0.003 cm 
intervals at a rotor speed of 40,000 rpm. Sedimentation analysis of the MaCCC 
cytoplasmic domain and the mutant R627A was performed at protein concentrations of 
15 μM. The His6-tag was removed unless stated explicitly. Data analysis was performed 
with the c(S) module of Sedfit (Schuck 2000; Schuck, Perugini et al. 2002). The buffer 
parameters, partial-specific volume of the protein, and the corrected sedimentation 
coefficients S°20W were calculated by using Sednterp. For data used in this analysis, the 
root-mean-square deviations of all the fits were between 0.005 and 0.01. 
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Crystallization and Crystal Preparation. All crystals were obtained by sitting drop 
vapor diffusion. Purified protein with a concentration of 8-15 mg/ml was mixed in a 1:1 
ratio with reservoir solution and was equilibrated against the reservoir. Crystals of the 
MaCCC domain in a trigonal crystal form were grown from protein construct lacking 
the 3C protease site and thus had the His6-tag attached. The reservoir solution contained 
100 mM MES (pH6.5), 1.1 M MgSO4. Crystals grew after 1-3 days at 4 °C in space 
group P3221 with one copy of the MaCCC domain in the asymmetric unit. Crystals of 
the MaCCC domain in the orthorhombic and tetragonal crystal forms were grown from 
protein where the His6-tag was removed. Crystals in the orthorhombic crystal form were 
grown in a reservoir solution containing 100 mM sodium acetate (pH4.6) and 750 mM 
MgCl2. Crystals grew after six days at 20 °C in space group C222 with two molecules in 
the asymmetric unit. Crystals of the tetragonal crystal form were grown from reservoir 
solution containing 100 mM Tris (pH 8.5) and 3.9 M ammonium chloride. Crystals 
grew after four days at 20 °C in space group I41 with four copies in the asymmetric unit.  
For cryoprotection, the crystals in all three crystal forms were successively transferred 
into mother liquor containing increasing amounts of glycerol to a final concentration of 
35%, flash-frozen in liquid propane and stored in liquid nitrogen. 
 
Crystallography. Data sets were collected on frozen crystals on the X06SA 
beamline at the Swiss Light Source (SLS) of the Paul Scherrer Institut (PSI) on a 
Mar225 CCD detector (Marresearch). The data were indexed, integrated and scaled with 
the programs XDS (Kabsch 1993), DENZO and SCALEPACK (Otwinowski and Minor 
1997) and further processed with CCP4 programs (Table 1) (CCP4 1994). The structure 
of the P3221 crystal form was determined by the SAD method using the anomalous 
contributions of Se-atoms in a crystal containing protein where methionine residues 
were replaced by selenomethionine.  The Se-sites were identified with SHELX C and D 
(Schneider and Sheldrick 2002; Pape and Schneider 2004) and refined with SHARP (de 
La Fortelle and Bricogne 1997). Phases were improved by solvent flattening in DM 
(Cowtan 1994). The model was built in O and refined by simulated annealing with the 
program CNS (Brunger, Adams et al. 1998) alternated with inspection and manual 
rebuilding in O. In later stages the refinement proceeded in a native dataset at 1.9 Å 
resolution with PHENIX (Adams, Grosse-Kunstleve et al. 2002).  Individual B-factors 
were refined and water molecules were placed into residual electron density. Rfree was 
calculated by selecting 10% of the reflection data that were omitted in refinement. 28 
residues at the N-terminus and in loop regions were not defined in the electron density 
and are thus not included in the model. The final has R/Rfree values of 19.8 % and 23.2 
%, good geometry and no outliers in the Ramachandran plot. The structures of the C222 
and I41 crystal forms were determined by molecular replacement with PHASER (A. J. 
McCoy 2007) using the refined MaCCC domain structure as search model and refined 
in PHENIX maintaining tight NCS constraints. 
 
  
3 General Discussion and Outlook 
In this work the structural organization of CCC transporters was investigated by 
biochemical methods and X-ray crystallography. Several prokaryotic homologues were 
identified and selected for expression, purification and crystallization studies. For all 
transporters three different expression constructs were designed encompassing either the 
full-length protein (section 2.3), the C-terminal domain (section 2.4) or the membrane 
domain (4.1). After broad expression screening and biochemical characterization the 
homologue of the archaea Methanosarcina acetivorans, MaCCC, was identified as the 
only protein where the three protein constructs could be expressed and purified in a 
stable state and in sufficient amounts for structural investigations. The  The C-terminal 
domain of MaCCC allowed the structure determination of this putative regulatory 
subunit and the analysis of its oligomeric state. From different crystal forms two 
potential dimer interfaces were obtained, one of which was identified with biochemical 
tools to correspond to the native interface. The dimeric organization observed in the 
domain was shown to be conserved in the context of the full-length protein by MALS 
and SDS-PAGE. Although promising progress towards the structural and functional 
characterization of prokaryotic CCCs was reached, the final goal of the structure 
determination of a full-length CCC transporter remains very challenging. 
Besides the improvement of expression, purification and crystallization, a future 
focus will be on functional investigations and the establishment of transport assays. 
MaCCC is clearly a very attractive protein for such studies since it is currently the only 
family member that has been purified in large quantities. The fact that the transport is 
electroneutral presents a challenge since it excludes most electrophysiological methods 
and it makes the transport independent of the membrane potential. However, insights 
into the transport properties and substrate specificity can potentially guide future 
purification and crystallization experiments. 
To overcome the inherent instability of the family in solution stabilizing compounds 
have to be explored further. These binders can be small molecules as well as high 
affinity proteinaceous binders and should stabilize one conformation of the transporter. 
Specific binders are also relevant with respect to potential ligands binding to the 
cytoplasmic domain and regulating transport that are currently unknown. Due to the 
lack of structural information on the full-length protein the binders have to be selected 
from libraries. Potential binding molecules to the cytoplasmic domains could also be 
identified by virtual docking of possible substrates. The binding could either be detected 
by fluorescence methods, or isothermal titration calorimetry (ITC), or the modulation of 
transport observed in a transport assay. ITC would be particularly suited for screening 
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with the isolated C-terminal domain. The generation of suitable binding proteins to the 
transporter will be of large importance for future crystallization experiments. First steps 
in this direction have been described by the selection of specific antibodies in mouse. 
Since these experiments, however, did not allow the identification of epitope specific 
antibodies, which are believed to be a prerequisite for such co-crystallization 
experiments other approaches will have to be investigated. Due to the instability of the 
proteins future attempts for the generation of binders should be done in vitro by e.g. 
display methods. This offers the chance to control the state of the protein and rapidly 
produce numerous binders for defined conformations oligomeric states and construct 
size. 
The work describe in this thesis has provided first structural information on the CCC 
family. A model of the current state of knowledge is summarized in Fig 3-1. The 
structure of the cytoplasmic domain was determined and has revealed a novel structure 
for a regulatory unit that might potentially interact with ligands to regulate transport in 
response to cellular signals. The identification of the ligand would provide novel 
important insight into the physiological processes that CCC transporters are involved in. 
The dimeric organization and the interface were confirmed with biochemical methods. 
The orientation of the C-terminal domain-dimer towards the membrane domain is based 
on the amino acid conservation mapping on the surface of the cytosolic domain. The 
identification of MaCCC as a well expressed and stable prokaryotic CCC transporter 
has established an important model system for future structural and functional 
 
Fig 3-1 Model for CCC Organization 
The C-terminal domains of MaCCC (green and yellow structures in cartoon) are connected to the 
membrane part (green and yellow box) with a linker (red). The structure of the membrane part (green and 
yellow boxes) are not determined yet. The membrane is depicted in grey. 
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investigation on a protein family that despite its importantance is still poorly 
understood.  
These results represent the first structural insights on the family of CCCs and showed 
its dimeric organization on the purified C-terminal domain and the purified full-length 
transporter of MaCCC. 
 
 
 
  
4 Appendix 
Despite the overall promising biochemical behavior of the full-length CCC from 
Methanosarcina acetivorans C2A, no crystallization was observed even with broad 
screening experiments. To overcome the crystallization bottleneck two strategies were 
pursued, which have already given preliminary results that are described in the appendix 
to this work and which include attempts to crystallize a transporter lacking the 
cytoplasmic domain and the generation of monoclonal antibodies for the subsequent co-
crystallization of the transporter in complex with Fab fragments. 
4.1 Membrane Domain of Prokaryotic CCCs 
4.1.1 MaCCC Membrane Domain 
In an attempt to improve the possibilities for successful crystallization of the MaCCC 
transporter the potential flexible C-terminal domain was removed and the 
overexpression of the isolated membrane part of MaCCC was investigated. Different 
constructs of the transmembrane domain were designed taking the information from 
hydropathy plots and the observed boundaries from the structure determination of the 
C-terminal into acount (Fig 4-1). 
With a protein fragment ending after the last predicted transmembrane segment at 
residue H450 no expression was observed under various conditions with the T7 
promoter using anti His-tag Western blot. A second construct considering experience 
from the C-terminal domain construct was created that ended at residue A473. With this 
construct little expression was detected by an anti His-tag immunoblot (Fig 4-2). The 
 
Fig 4-1 MaCCC Amino Acid Sequence of the Linker Between the Membrane Domain and the C-
Terminal Domain 
MaCCC membrane domain construct design: The truncation of MaCCC to remove the potentially flexible 
C-terminal domain was based on hydropathy analysis from the experience obtained from the structure 
determination of the separate cytosolic domain. A section of the MaCC sequence is shown with the last 
predicted transmembrane domain [TM12] and the start of the C-terminal domain structure [β 1] indicated. 
The construct for the expression of the C-terminal domain started at V472. The expression tests were 
conducted with a construct ending at residue H450 and the second trial with A473. A broad expression 
screen was performed with constructs varied by five amino acids in length from TM12 to β1 (arrows). 
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low signal that points towards low expression of this construct has led to the design of 
various constructs with different length of the linker after the membrane domain and the 
C-terminal domain. 
These expression tests were carried out with constructs, whose sequences were 
extended in steps of five residues after the last predicted transmembrane helix of 
MaCCC at residue H450 (i.e. residue H450) (Fig 4-1). The constructs were created 
using FX cloning into pBXGC3H including C-terminal GFP fusion (Fig 2-4). Three 
clones for each construct were investigated for their expression behavior at different 
arabinose concentration in a 96 well plate format by induction overnight at 25 °C and 
analyzed by monitoring the GFP fluorescence (Fig 4-3B). All constructs show 
expression with different yields. The highest expression was recorded for a construct 
that terminated domain at residue R490 followed by N495 and T485. These constructs 
have comparably long tail after the proposed end of the membrane domain. 
 
Fig 4-2 MaCCC Membrane Domain Expression Test 
MaCCC was truncated after the last predicted transmembrane segment and before the start of the 
cytosolic domain at residue A473. After growing in TB media to an OD600nm=0.5 at 37 °C the expression 
was induced with 0.5 mM IPTG for 3 h. Four clones (1 - 4) were tested. Two of them (clone 1 and 2) 
showed weak expression (arrow) that is not sufficient for purification and characterization. The signals 
for clone 3 and 4 were not detectable. 
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The highest expressing clone for each construct was analyzed by extraction and size 
exclusion chromatography monitoring the fluorescence of the GFP fusion of the cell 
A 
 
 
 
B 
 
Fig 4-3 Expression Test of MaCCC Membrane Domain 
The membrane domain of MaCCC was tested for overexpression with different constructs differing in the 
length of their C-terminal tail. (A) On a 96 well plate (A to H and 1 to 12) three clones (#A-C) were 
tested at different arabinose concentrations (0.01, 0.001, 0.0001 % (w/v)) for expression. The best 
expressing clones are highlighted in red. (B) The fluorescence of the C-terminal attached GFP was 
recorded with red highest expression and blue lowest expression. 
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extracts. After breakage of the cells the lysed cells were solubilized with DDM followed 
by high spin centrifugation. The supernatant was injected onto an analytical gel 
filtration column attached to an HPLC system (Agilent) and detected by measurement 
of GFP fluorescence (Fig 4-4). For all tested constructs a strong peak was present at a 
volume of 7.9 ml, except for T485#B. The retention volume of 7.9 ml corresponds to an 
apparent molecular weight of 120 kD. For two constructs (R490#C and N495#C) an 
additional peak at 7.4 ml was recorded which corresponds to an apparent weight of 
300 kD. It appears that the truncated protein exists in two different oligomeric states 
which are influenced by increasing length of the C-terminal tail. 
Future experiments for the membrane domain will include the scale-up of expression 
and purification of the protein. If the protein yields after scale-up are sufficient, the 
protein will be subjected to crystallization screening. 
4.2 Antibody Production 
4.2.1 Binding Molecules that Facilitate Crystallization 
A strategy to support crystallization of membrane proteins is the use of soluble high 
affinity binders that form tight complexes with the membrane protein (Koide 2009). The 
 
Fig 4-4 MaCCC Membrane Domain F-HPLC 
The MaCCC membrane domain was analyzed by HPLC recording the fluorescence of the C-terminal 
attached GFP. The fluorescence in artificial units [AU] is plotted against the retention volume [ml].  
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increased hydrophilic surface of the complex provides specific interactions for crystal 
contact formation. Since crystal contacts are predominantly mediated by hydrophilic 
surfaces the binding protein significantly increase the hydrophilic area of membrane 
proteins, whose hydrophobic membrane inserted regions are covered by detergents upon 
solubilization. Specific binding proteins potentially also stabilize certain conformations 
of a membrane protein and such allow to obtain a homogenous sample. This property 
can be of big importance for transport proteins that undergo large conformational 
changes during the transport cycle. Most common used binders in crystallography are 
antibody derived binders like Fabs (fragments of the antibody binding regions), Fv‟s 
(fragment of the variable region) and scFv (single chain Fv fragment). DARPins 
(designed ankyrin repeat proteins) present another group of soluble high affinity binders 
that have been explored recently. While antibodies are still predominantly derived from 
natural sources, after immunization of animals and by the generation of hybridoma cell 
s, recombinant antibody fragments selected from engineered libraries became an 
important alternative during the last years. DARPins in contrast are selected from large 
libraries by ribosome display techniques. 
Fabs are built up from the variable and constant parts of the light chains and the N-
terminal halve of the heavy chain of IgGs. They can be generated by partial proteolytic 
digest of IgGs with papain. Fv‟s are composed of the variable parts of heavy and light 
chains only and are usually linked via a short peptide linker in scFv (Fig 4-5). The 
chloride channel from E. coli, EcClC, was successfully crystallized with Fabs. These 
binders facilitated the crstallyzation and structure determination of this channel by 
increasing the hydrophilic surface (Fig 4-7A). 
 
Fig 4-5 Antibody Molecules and Fragments 
IgG are part of the immune system and created through hybridoma technology. They consist of two 
chains, heavy (blue) and light (green) chain. Interaction between the chains and several cysteine bridges 
(black) stabilize the structure. The complementary defining regions (CDRs)  are important for antigen and 
are located on the tips of the arms (red). Through proteolytic cleavage in the linker region (wavy line) in 
the heavy chain with papain Fabs are created. For crystallization the more stiff and defined Fab-, Fv and 
scFv molecules are used. 
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DARPins are assembled in a modular fashion that allows a high stability combined 
with high diversity in target binding. The general framework consensus sequence that 
was derived from natural ancestors is enclosed by protecting N- and C-terminal capping 
region to create a stable protein (Fig 4-6). A varying amount of repeats between the caps 
with defined randomized residues, covered by a large library allows the selection of 
recombinant binders for various targets.  
DARPins have presently only once been successfully used in membrane protein 
crystallization where they were stabilizing one conformation in the transport cycle of 
 
Fig 4-6 Shematic Representation of DARPins 
Designed akyin repeat proteins (DARPins) are built up modular. The binding modules have a defined 
structure encoded by a consensus sequence. Residue varitions at restricted positions (red area) assemble 
the library for ribosome display. Variation in binding affinity and specificity is reached by variation of the 
repeat number (N=3 is shown). The N- and C-terminal caps shield the hydrophobic core and generate a 
stable protein. 
 
Fig 4-7 Co-Crystallization with Proteinaceous Binders 
Co-crystallization with binders has various effects on the crystallization behavior. (A) It can dramatically 
increase the hydrophilic surface and thus be essential for crystal contacts like in EcClC (grey surface) 
with two Fabs (green and blue, light and heavy chain, respectively). (B) The binders can also fix a certain 
conformation and allow the structure determination of distinct transport states like AcrB (grey surface) in 
complex with two DARPins (red). EcClC (1ots); AcrB (2j8s). 
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the major drug efflux pump AcrB. Through selection and binding a homogenous protein 
species was generated that showed improved crystallization properties (Fig 4-7B). The 
formation of novel crystal contacts by an increase of the polar surface was in this case 
not observed. 
4.2.2 Production and Identification of Positive Hybridoma Cell Lines 
The unsuccessful crystallization screening of MaCCC motivated the production of 
specific binding proteins for the subsequent crystallization of complexes with the 
transporter. The production of monoclonal antibodies was the first choice since since 
this approach has already been successful in various membrane protein structure 
determinations. Mouse was chosen as organism for immunization with the antigen. All 
experiments were carried out in collaboration with CEPower, a company specialized for 
the generation of monoclonal antibodies in Wädenswil close to Zurich. Three mice were 
immunized with MaCCC in its putative monomeric conformation. The immunization 
was repeated twice before harvesting of the mouse spleen. The fusion of the B-
lymphocytes from spleen cells of two mice with myeloma cells to form immortalized 
hybridoma cells expressing IgGs was carried out by standard methods and confirmed 
with selection in hypoxanthine aminopterin thymidine (HAT) medium. HAT medium is 
a selection medium where the drug aminopterin inhibits the dihydrofolate reductase, 
which results in an impairment of nucleotide de novo synthesis. The synthesis of 
thymine can be bypassed with thymidine and of guanine with hypoxanthine. Only 
fussed cells carrying the immortalization of the myeloma cells and the hypoxanthine-
guanine phosphoribosyltransferase (HGPRT) of B-lymphocytes can survive during this 
selection. 497 stable hybridoma cell lines were grown and all supernatants containing 
secreted antibodies were screened by ELISA for a reaction against MaCCC. All ELISA 
signals above background were selected to have a maximum set of potential antibodies 
for a thorough investigation. With this procedure 51 antibody expressing clones, SW01 
to SW51, were identified. These 51 clones were analyzed by ELISA on the same plate 
for their binding against MaCCC full-length and the C-terminal domain of MaCCC (Fig 
4-8). Only few monoclonal antibodies show a strong signal against the full-length 
protein (SW27, 34, 35) (Fig 4-8B), or the isolated domain (SW3, 27, 28, 34, 35) (Fig 
4-8C). Several antibodies appear to bind solely to the full-length protein, but with an 
ELISA signal only slightly above background (SW 7, 9, 12, 13, 16, 19, 20, 22, 26, 30, 
33, and 49). The antibody concentration in the supernatants was estimated by coating 
the ELISA plate with the antibody containing hybridoma supernatant and by using an 
antibody against mouse IgG for the reaction. All supernatants of the selected clones 
SW1-51 had similar amounts of antibody but they all were very low compared to 
antibody amounts generated from a hybridoma cell line expressing an antibody against 
the chloride transporter EcClC that was used as positive control. Since the signals 
recorded in different ELISAs for the same sample showed a high variance, the clone 
SW10, 42 and 47 were added to the list of potential candidates for in-depth 
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characterization. Since for the initial characterization hybridoma cell supernatants 
containing the monoclonal antibodies were used, a next step includes the purification of 
antibodies and the analysis of binding against MaCCC by ELISA and by complex 
formation in solution after the isolation of the Fab fragments. 
Selected clones that showed a high siganl signal against MaCCC were characterized 
by Western blotting. The characterization of binding against the denatured protein by 
Western blot analysis allows the discrimination between sequence epitopes (which 
show signals in a Western blot analysis) from the structural epitopes (which do not 
show a signal since the structural epitope is lost on a denaturing gel). Antibodies that 
recognize structural epitopes are believed to be better suited for crystallization because 
their interaction with the antigen usually causes the formation of a rigid complex. 
A 
 
 
B         C 
 
Fig 4-8 Antibody Binding Against MaCCC Full-Length and C-Terminal Domain 
The selected antibodies SW1 to SW51 were tested for their binding properties to the full-length protein 
and to the C-terminal domain of MaCCC. (A) The supernatants of growing hybridoma cultures were used 
as primary antibody in an ELISA against (B) the full-length MaCCC and against (C) the C-terminal 
domain. The chemiluminescence was recorded after incubation of a secondary anti mouse antibody 
coupled to horse radish peroxidise. 
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Sequence epitopes can be unstructured N- or C-terminal tails as well as unstructured 
loop regions. Purified MaCCC was separated by SDS PAGE and blotted on a PVDF 
membrane that was subsequently blocked with milk to saturate non-specific protein 
binding sites. Sections of the PVDF membrane all containing MaCCC and a protein 
standard marker lane were incubated with the antibody containing supernatants of the 
selected hybridoma cells. After incubation with the secondary antibody and the 
detection of chemiluminescence, only one clone. SW 27, showed a signal, indicating 
that this antibody recognizes a sequence specific epitope. The SW27 clone also had the 
strongest signal in the ELISA reaction against the full-length proteins and the C-
terminal domain. O clones did not show a signal in Western blot indicating that they do 
not recognize the disordered protein regions. 
4.2.3 Fab Production and Purification 
The yield of monoclonal antibody from hybridoma cell culture in cell line flasks (BD 
Biosciences) was low, and the amount of purified Fabs after cleaving and purification 
was too low for efficient and reliable testing of the antibody properties in solution. An 
overproduction in collaboration with CE-Power in roller bottles was more successful 
but still the yield was severall orders of magnitude below the yield obtained from 
hybridoma cell line expressing the EcClC antibody (2 - 4 mg/l for CCC antibody 
compared to 100 mg/l for the EcClC antibody). While the generation and purification of 
Fab fragments from IgG of SW 10, 22, 42, 47 and SW 49 was successful, the overall 
yields were very low due to various dialysis, cutting and affinity purification steps. 
After the experiences with low yield of antibody overproduction with hybridoma 
cells another strategy was chosen to generate Fab fragments by cloning and 
heterologous overexpression E. coli. These experiments were carried out with the help 
of Laura Prochazka, a master student who established the cloning and expression of Fab 
 
Fig 4-9 Epitope Characterization of Selected Monoclonal Antibodies 
MaCCC was separated by SDS-PAGE and Western blotted. After separate incubation with the hybridoma 
supernatant of the indicated clone the blot lanes were developed using anti mouse antibodies and 
chemiluminaescene. 
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fragments. The two chains of Fab fragments were clones independently and directed to 
the periplasm of E. coli. To facilitate a high throughput analysis of the selected binders 
a combined FX and VBex cloning was chosen. The variable regions of both, heavy and 
light chains were amplified from cDNA of hybridoma cell lines. In the first FX cloning 
step, the variable regions of both chains were cloned in separate vectors. During cloning 
the variable parts were cloned on the 5‟ side of the vector containing the constant part of 
the human heavy and light chains, respectively. The second VBex step merged the two 
chains into a polycistronic vector containing both, heavy and light chain. The operon is 
controlled by the PLAC promoter. Additionally both proteins start with different export 
signals (phoA for the heavy chain and ompA for the light chain) for periplasmic 
targeting and assembly of the Fabs. For later purification the heavy chain was fused to a 
His6-tag on its C-terminus. 
For amplification of the antibody fragments, whole cell mRNA of cultivated 
hybridoma cells was isolated in sufficient amounts to be translated into cDNA by 
reverse transcriptase with degenerated primers. The difficult amplification of the 
variable part of the heavy and light chain from the cDNA pool was accomplished with 
degenerated primer pairs designed based on of multiple antibody sequences. By this 
strategy Fab fragments of all selected antibodies were cloned. 
For the overexpression of the Fab constructs a standard procedure was chosen. E. 
coli transformed with the expression plasmid was grown until the mid exponential state 
at 37 °C and induced with 0.1 mM IPTG at 25 °C overnight. After harvesting and 
breakage of the cells, Fabs were purified by IMAC and analyzed by SEC. Several 
purified Fabs show a monodisperse peak on SEC which indicates well-folded protein 
(Fig 4-10A). 
4.2.4 Fab Binding Analysis 
The purified Fabs were investigated for binding to MaCCC by ELISA in comparison 
to the signal of the hybridoma supernatant of the selected clones (Fig 4-11). After 
coating with MaCCC and incubation with the supernatant and the purified Fab the 
reactions were developed with anti mouse and anti His-tag antibodies, respectively. The 
highest signal was observed for the sequence specific clone SW27. It showed a strong 
signal for the hybridoma supernatant and a comparably strong signal (six times above 
background) for the expressed Fab. Although the supernatants of SW10 and SW12 
showed also a signal above background for the hybridoma supernatant, the signal for 
the expressed Fab was very weak. Only for SW12 a signal above background was 
detected. SW35 in constrast did not show any signal for the hybridoma supernatant and 
the Fab. 
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To investigate the formation of a stable complex MaCCC was incubated with the 
 
Fig 4-11 Anti-MaCC Fab Binding Test 
Comparative ELISA analysis of hybridoma supernatant and purified Fab binding to MaCCC. (A) The 
chemiluminescence was recorded after coating with MaCCC and incubation with the samples and 
development with HRP. (B) Column 1 represents the hybridoma supernatant samples that were detected 
with anti mouse antibodies while in column 3 the purified Fabs were tested with detection through the 
His-tag on the heavy chain with an anti His-tag antibody. Column 2 and 4 are the background signals for 
the detection methods. 
 
Fig 4-10 Purification and Binding of SW27 Fab 
(A) SW27 Fab with a C-terminal His-tag on the heavy chain was purified using IMAC and SEC. The 
SEC fractions were analyzed by Western blot with anti His-tag antibody (black quadrate) and anti mouse 
light chain antibody (asterisk) and overlaid. (B) Binding of SW27 Fab to MaCCC was proven by co-
migration on SEC and silver stain of the fractions after SDS-PAGE. (quadrate-heavy chain, asterisk-light 
chain, triangle-MaCCC). 
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respective Fab fragment for 30 min at 4 °C at a ratio of 3 mol Fab to 1 mol MaCCC. 
Since specific Fab fragments usually have a very high affinity in the nano-molar range 
at three-times excess of Fabs was expected to be sufficient for a quantitative complex 
formation. The complex was investigated by SEC to observe the coelution of MaCCC 
and Fabs and to separate unbound Fab from the complex. Since SW27 showed strongest 
binding to MaCCC it was selected for the binding experiment (Fig 4-10B). In the SEC 
experiment the peak of MaCCC with an elution volume of 11.9 ml was shifted to an 
elution of 11 ml, due to the binding of the SW27 Fab as shown by SDS-PAGE of the 
SEC fractions. 
Unfortunately SW27 proves to be the only Fab that showed binding to MaCCC in 
solution (Tab 4-1) whereas other Fabs that also had low signals on ELISA did not bind 
to MaCCC. 
 
4.2.5 Materials and Methods 
 
96 Well Expression Test. The truncated constructs for the MaCCC membrane 
domain were cloned into pBXGC3H vector (Fig 2-5B) and three clones were picked 
from each construct for overnight preculture in LB medium at 37 °C. A 96 2.2 ml deep 
well plate (round bottom, Thermo Scientific) was filled with 1 ml TB medium and 
inoculated with 1 % preculture and closed with gas permeable seals (Thermo 
Clone Source Fab binding 
SW9 E. coli No 
SW10 hybridoma cells/ E. coli No/(ELISA) 
SW12 E. coli No 
SW22 hybridoma cells No 
SW27 E. coli ELISA and SEC 
SW28 E. coli No 
SW35 E. coli No 
SW42 hybridoma cells No 
SW47 hybridoma cells No 
SW49 hybridoma cells No 
Tab 4-1 Fab Binding to MaCCC 
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Scientific). After growth at 37 °C with vigorous shaking until OD600nm=0.5 (~135 min) 
the cells were immediately cooled to 25 °C and induced with 10
-3
 (w/v) arabinose. After 
overnight incubation the cells were centrifuged and the OD600nm was determinate by 
resuspension of the cell pellet in 100 µl PBS and measurement of an at least 1:9 dilution 
to 100 µl in a MaxiSorp (Nunc) 96 well plate. Before the resuspended cells were 
analyzed for fluorescence (λabsorption=485 nm, λemission=535 nm) in a 96 black well plate 
(Nunc) with a Tecan GENios system and with the Magellan software. After addition of 
300 μl ice-cold lysis buffer (50 mM KPi (pH 7.2), 150 mM NaCl, 1 mM MgSO4, 10 % 
(w/v) glycerol, 1 mM PMSF and 20 µg/ml DNase) and 300 mg glass beads (0.1 mm 
diameter) the samples were broken in a FastPrep device (Bio101) for two times 20 s at 
force 6 with 5 min cooling on ice between the runs. 100 µl of the lysed cell suspension 
was incubated with 25 µl 10 % DDM for 1 h at 4 °C and high-spin centrifuged (30 min, 
4 °C,  x g). 10 to 30 µl were injected onto a Zorbax GF-250 column (Agilent) using a 
HPLC system with fluorescence detector (8 µl FLD cell, Agilent Technologies 1200 
Series). 
 
ELISA. 96 well MaxiSorp plates (Nunc) were coated with 100 µl of 100 nM protein 
in buffer B (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM DM) and incubated for 2 h 
at 4 °C. After washing 3 times for 5 min with 200 µl buffer B the plate was blocked for 
1 h at with 300 µl buffer B + 5 % BSA (w/v) and subsequently washed. After 
incubation with 100 µl hybridoma supernatants (1:1 mixed with 2 x buffer B with 4 % 
BSA (w/v)) for 1 h at and washing, the plate was incubated for 1 h at room temperature 
with 100 µl goat-antimouse-HRP antibody diluted in buffer B + 2 % BSA (w/v) for 1 h. 
After washing the plate was developed with 100 µl prepared TMB substrate (Sigma) 
and stopped with 100 µl 1 M HCl. The signal was measured with absorbance at 450nm. 
All steps were carried out at room temperature if not stated different. 
 
Immunization of Mice and Fusion to Myeloma cells. The immunization was 
carried out by CE Power only the target protein was prepared and supplied. Three mice 
were immunized with 300 µl of 200 µg/ml target protein. This procedure was repeated 
two times and 10 days after the last immunization the spleen cells were harvested. The 
spleen B-cells were fused to myeloma cells (ΔHGPRT) and cloned with limited 
dilution. The supernatants were tested for positive clones by ELISA. 
 
Expression of IgGs. Hybridoma cells were thawed and after removal of DMSO by 
centrifugation and resuspension in hybridoma medium supplemented with 5 % fetal calf 
serum (FCS) and 2 % L-glutamine the cells were grown with at least two passages until 
cell densities of 2 x 10
6
/ml. The CELLine 1000 device (BD Biosciences) was prewetted 
and 15 ml of high density hybridoma cells were filled into the cell compartment 
followed by filling 1 l of prewarmed medium in the nutrient compartment. After 
incubation for seven days the cell were aspirated using a serological pipet, cenrifugated 
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with keeping the IgG containing supernatant and the cell pellet was diluted to reach the 
mentioned density and refilled into the cell compartment. This procedure can be 
repeated twice and after 21 days of growth the feeding medium has to be replaced. 
 
Preparation of Fabs from IgGs. The hybridoma supernatant was dialyzed against 
overnight (MWCO=8000 Da). MonoQ sepharose fast flow (Pharmacia) was 
equilibrated with dialysis buffer and the sample was loaded. The protein was eluted 
with a gradient from 10 mM NaCl to 400 mM NaCl in 10 mm Tris-HCl pH 8.0. The 
first peak was collected and dialyzed overnight against PBS and the antibody diluted to 
OD280nm=1.5 The cutting was performed after addition of 10 mM β-mercaptothanol, 
10 mM L-cysteine, 10 mM EDTA (pH 7.0) and incubation for 30 min with the addition 
of papain at a ratio 1:100, papain:IgG. After completion of the cutting the reaction was 
stopped with 23 mM iodoacetamine for 20 min at 37 °C. After dialysis overnight 
(MWCO=1000 Da) against 10 mM Tris-HCl pH 8.0, 10 mM NaCl the Fabs and Fcs 
were separated by MonoQ sepharose. Fabs were in the flow-through. 
 
Cloning of Fabs. According to Master thesis Laura Prochazka, Zurich 2009 
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